search
Back to results

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Primary Purpose

Stroke

Status
Completed
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
Aggrenox
Aggrenox
Clopidogrel placebo
Clopidogrel placebo
Micardis
Micardis
Aggrenox placebo
Aggrenox placebo
Clopidogrel
Clopidogrel
Micardis placebo
Micardis placebo
Sponsored by
Boehringer Ingelheim
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Stroke

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: Male or female subjects 55 year or older who have suffered an ischemic stroke within the past 90 days and who meet all other inclusion criteria. Include also patients of ages 50 - 54 years and/or 90 to 120 days after the qualifying stroke provided the patient has at least two of the following additional risk factors: Diabetes mellitus Hypertension (systolic BP ¿ 140 or diastolic BP ¿ 90) Smoker at time of qualifying stroke Obesity (BMI>30; BMI=weight (kg)/[height (m)]2) Previous vascular disease (stroke, MI, or peripheral arterial disease prior to qualifying stroke) End-organ-damage (retinopathy, LVH, or microalbuminuria) Hyperlipidemia Exclusion criteria: hemorrhagic stroke (must be ruled out by imaging);unable to give informed consent; known brain tumor, severe renal or hepatic insufficiency, current active peptic ulcer disease, severe coronary artery disease including unstable angina pectoris or an MI within the previous 3 months,or history of a hemostatic disorder or systemic bleeding ;hyperkalemia;uncorrected volume or sodium depletion; pre-stroke history of dementia;modified Rankin score greater than 4;qualifying stroke induced by surgical or cardiovascular procedure;uncontrolled hypertension at entry above 180/110 mmHg (goal BPs are lower); SBP 120 mmHg or less for hospitalized patients; currently taking an ARB and not able or willing to switch to alternative; required or planned continuing treatment with antithrombotics or anticoagulants including heparin or warfarin or non-study platelet inhibitors; syndrome of asthma, rhinitis and nasal polyps;scheduled for major surgery, carotid endarterectomy, or carotid angioplasty (4 weeks post surgery is allowed);unlikely to be released from hospital following the qualifying stroke or presence of a severe disability likely to lead to being bedridden or demented or a non-vascular disease or condition which makes it unlikely that the patient will survive to the end of the trial; history of thrombocytopenia or neutropenia.

Sites / Locations

  • 9.159.1101 Boehringer Ingelheim Investigational Site
  • 9.159.1173 Boehringer Ingelheim Investigational Site
  • 9.159.1058 Boehringer Ingelheim Investigational Site
  • 9.159.1087 Boehringer Ingelheim Investigational Site
  • 9.159.1081 Boehringer Ingelheim Investigational Site
  • 9.159.1022 Boehringer Ingelheim Investigational Site
  • 9.159.1133 Boehringer Ingelheim Investigational Site
  • 9.159.1149 Boehringer Ingelheim Investigational Site
  • 9.159.1137 Boehringer Ingelheim Investigational Site
  • 9.159.1184 Boehringer Ingelheim Investigational Site
  • 9.159.1005 Boehringer Ingelheim Investigational Site
  • 9.159.1136 Boehringer Ingelheim Investigational Site
  • 9.159.1062 Boehringer Ingelheim Investigational Site
  • 9.159.1040 Boehringer Ingelheim Investigational Site
  • 9.159.1180 Boehringer Ingelheim Investigational Site
  • 9.159.1114 Boehringer Ingelheim Investigational Site
  • 9.159.1202 Boehringer Ingelheim Investigational Site
  • 9.159.1036 Boehringer Ingelheim Investigational Site
  • 9.159.1052 Boehringer Ingelheim Investigational Site
  • 9.159.1100 Boehringer Ingelheim Investigational Site
  • 9.159.1111 Boehringer Ingelheim Investigational Site
  • 9.159.1165 Boehringer Ingelheim Investigational Site
  • 9.159.1134 Boehringer Ingelheim Investigational Site
  • 9.159.1002 Boehringer Ingelheim Investigational Site
  • 9.159.1108 Boehringer Ingelheim Investigational Site
  • 9.159.1013 Boehringer Ingelheim Investigational Site
  • 9.159.1198 Boehringer Ingelheim Investigational Site
  • 9.159.1029 Boehringer Ingelheim Investigational Site
  • 9.159.1185 Boehringer Ingelheim Investigational Site
  • 9.159.1218 Boehringer Ingelheim Investigational Site
  • 9.159.1179 Boehringer Ingelheim Investigational Site
  • 9.159.1162 Boehringer Ingelheim Investigational Site
  • 9.159.1183 Boehringer Ingelheim Investigational Site
  • 9.159.1205 Boehringer Ingelheim Investigational Site
  • 9.159.1118 Boehringer Ingelheim Investigational Site
  • 9.159.1045 Boehringer Ingelheim Investigational Site
  • 9.159.1038 Boehringer Ingelheim Investigational Site
  • 9.159.1196 Boehringer Ingelheim Investigational Site
  • 9.159.1018 Boehringer Ingelheim Investigational Site
  • 9.159.1080 Boehringer Ingelheim Investigational Site
  • 9.159.1120 Boehringer Ingelheim Investigational Site
  • 9.159.1216 Boehringer Ingelheim Investigational Site
  • 9.159.1057 Boehringer Ingelheim Investigational Site
  • 9.159.1217 Boehringer Ingelheim Investigational Site
  • 9.159.1096 Boehringer Ingelheim Investigational Site
  • 9.159.1144 Boehringer Ingelheim Investigational Site
  • 9.159.1007 Boehringer Ingelheim Investigational Site
  • 9.159.1190 Boehringer Ingelheim Investigational Site
  • 9.159.1150 Boehringer Ingelheim Investigational Site
  • 9.159.1153 Boehringer Ingelheim Investigational Site
  • 9.159.1041 Boehringer Ingelheim Investigational Site
  • 9.159.1072 Boehringer Ingelheim Investigational Site
  • 9.159.1063 Boehringer Ingelheim Investigational Site
  • 9.159.1208 Boehringer Ingelheim Investigational Site
  • 9.159.1049 Boehringer Ingelheim Investigational Site
  • 9.159.1176 Boehringer Ingelheim Investigational Site
  • 9.159.1071 Boehringer Ingelheim Investigational Site
  • 9.159.1079 Boehringer Ingelheim Investigational Site
  • 9.159.1181 Boehringer Ingelheim Investigational Site
  • 9.159.1138 Boehringer Ingelheim Investigational Site
  • 9.159.1070 Boehringer Ingelheim Investigational Site
  • 9.159.1107 Boehringer Ingelheim Investigational Site
  • 9.159.1189 Boehringer Ingelheim Investigational Site
  • 9.159.1026 University of Illinois
  • 9.159.1033 Boehringer Ingelheim Investigational Site
  • 9.159.1060 Boehringer Ingelheim Investigational Site
  • 9.159.1044 Boehringer Ingelheim Investigational Site
  • 9.159.1054 Boehringer Ingelheim Investigational Site
  • 9.159.1068 Boehringer Ingelheim Investigational Site
  • 9.159.1178 Boehringer Ingelheim Investigational Site
  • 9.159.1156 Boehringer Ingelheim Investigational Site
  • 9.159.1092 Boehringer Ingelheim Investigational Site
  • 9.159.1027 Boehringer Ingelheim Investigational Site
  • 9.159.1119 Boehringer Ingelheim Investigational Site
  • 9.159.1187 Boehringer Ingelheim Investigational Site
  • 9.159.1059 Boehringer Ingelheim Investigational Site
  • 9.159.1135 Boehringer Ingelheim Investigational Site
  • 9.159.1090 Boehringer Ingelheim Investigational Site
  • 9.159.1129 Central Baptis Hospital
  • 9.159.1131 Boehringer Ingelheim Investigational Site
  • 9.159.1206 Boehringer Ingelheim Investigational Site
  • 9.159.1212 Boehringer Ingelheim Investigational Site
  • 9.159.1091 Boehringer Ingelheim Investigational Site
  • 9.159.1147 Boehringer Ingelheim Investigational Site
  • 9.159.1106 Boehringer Ingelheim Investigational Site
  • 9.159.1194 Boehringer Ingelheim Investigational Site
  • 9.159.1083 Boehringer Ingelheim Investigational Site
  • 9.159.1195 Boehringer Ingelheim Investigational Site
  • 9.159.1024 Boehringer Ingelheim Investigational Site
  • 9.159.1055 Boehringer Ingelheim Investigational Site
  • 9.159.1139 Boehringer Ingelheim Investigational Site
  • 9.159.1031 Boehringer Ingelheim Investigational Site
  • 9.159.1066 Boehringer Ingelheim Investigational Site
  • 9.159.1104 Boehringer Ingelheim Investigational Site
  • 9.159.1166 Boehringer Ingelheim Investigational Site
  • 9.159.1192 Boehringer Ingelheim Investigational Site
  • 9.159.1039 Boehringer Ingelheim Investigational Site
  • 9.159.1019 Boehringer Ingelheim Investigational Site
  • 9.159.1048 Boehringer Ingelheim Investigational Site
  • 9.159.1089 Boehringer Ingelheim Investigational Site
  • 9.159.1078 Boehringer Ingelheim Investigational Site
  • 9.159.1143 Boehringer Ingelheim Investigational Site
  • 9.159.1102 Boehringer Ingelheim Investigational Site
  • 9.159.1011 Boehringer Ingelheim Investigational Site
  • 9.159.1132 Boehringer Ingelheim Investigational Site
  • 9.159.1088 Boehringer Ingelheim Investigational Site
  • 9.159.1158 Boehringer Ingelheim Investigational Site
  • 9.159.1084 Boehringer Ingelheim Investigational Site
  • 9.159.1097 Boehringer Ingelheim Investigational Site
  • 9.159.1113 Boehringer Ingelheim Investigational Site
  • 9.159.1128 St. Luke's Hospital MABSI Research
  • 9.159.1172 Boehringer Ingelheim Investigational Site
  • 9.159.1174 Boehringer Ingelheim Investigational Site
  • 9.159.1009 Boehringer Ingelheim Investigational Site
  • 9.159.1182 Boehringer Ingelheim Investigational Site
  • 9.159.1191 Boehringer Ingelheim Investigational Site
  • 9.159.1146 Boehringer Ingelheim Investigational Site
  • 9.159.1201 Boehringer Ingelheim Investigational Site
  • 9.159.1127 Boehringer Ingelheim Investigational Site
  • 9.159.1188 Boehringer Ingelheim Investigational Site
  • 9.159.1204 Boehringer Ingelheim Investigational Site
  • 9.159.1203 Boehringer Ingelheim Investigational Site
  • 9.159.1042 Neurology Consultants of Burlington County
  • 9.159.1209 Boehringer Ingelheim Investigational Site
  • 9.159.1125 Boehringer Ingelheim Investigational Site
  • 9.159.1095 Boehringer Ingelheim Investigational Site
  • 9.159.1170 Boehringer Ingelheim Investigational Site
  • 9.159.1086 Boehringer Ingelheim Investigational Site
  • 9.159.1121 Boehringer Ingelheim Investigational Site
  • 9.159.1130 Boehringer Ingelheim Investigational Site
  • 9.159.1017 Boehringer Ingelheim Investigational Site
  • 9.159.1064 Boehringer Ingelheim Investigational Site
  • 9.159.1186 Boehringer Ingelheim Investigational Site
  • 9.159.1151 Boehringer Ingelheim Investigational Site
  • 9.159.1076 North Shore University Hospital
  • 9.159.1037 Boehringer Ingelheim Investigational Site
  • 9.159.1220 Boehringer Ingelheim Investigational Site
  • 9.159.1001 Boehringer Ingelheim Investigational Site
  • 9.159.1116 Boehringer Ingelheim Investigational Site
  • 9.159.1142 Saint Luke's-Roosevelt Hospital
  • 9.159.1126 Boehringer Ingelheim Investigational Site
  • 9.159.1163 Boehringer Ingelheim Investigational Site
  • 9.159.1169 Boehringer Ingelheim Investigational Site
  • 9.159.1065 Boehringer Ingelheim Investigational Site
  • 9.159.1099 Boehringer Ingelheim Investigational Site
  • 9.159.1046 Boehringer Ingelheim Investigational Site
  • 9.159.1094 Boehringer Ingelheim Investigational Site
  • 9.159.1012 Boehringer Ingelheim Investigational Site
  • 9.159.1115
  • 9.159.1051 Boehringer Ingelheim Investigational Site
  • 9.159.1110 Boehringer Ingelheim Investigational Site
  • 9.159.1215 Boehringer Ingelheim Investigational Site
  • 9.159.1152 Boehringer Ingelheim Investigational Site
  • 9.159.1159 Boehringer Ingelheim Investigational Site
  • 9.159.1085 Boehringer Ingelheim Investigational Site
  • 9.159.1032 Boehringer Ingelheim Investigational Site
  • 9.159.1025 Boehringer Ingelheim Investigational Site
  • 9.159.1177 Boehringer Ingelheim Investigational Site
  • 9.159.1008 Boehringer Ingelheim Investigational Site
  • 9.159.1141 Boehringer Ingelheim Investigational Site
  • 9.159.1053 Boehringer Ingelheim Investigational Site
  • 9.159.1122 Boehringer Ingelheim Investigational Site
  • 9.159.1199 Boehringer Ingelheim Investigational Site
  • 9.159.1010 Boehringer Ingelheim Investigational Site
  • 9.159.1171 Boehringer Ingelheim Investigational Site
  • 9.159.1210 Boehringer Ingelheim Investigational Site
  • 9.159.1214 Boehringer Ingelheim Investigational Site
  • 9.159.1200 Boehringer Ingelheim Investigational Site
  • 9.159.1043 Boehringer Ingelheim Investigational Site
  • 9.159.1164 Boehringer Ingelheim Investigational Site
  • 9.159.1175 Boehringer Ingelheim Investigational Site
  • 9.159.1016 Boehringer Ingelheim Investigational Site
  • 9.159.1056 Boehringer Ingelheim Investigational Site
  • 9.159.1074 Boehringer Ingelheim Investigational Site
  • 9.159.1112 Boehringer Ingelheim Investigational Site
  • 9.159.1148 Boehringer Ingelheim Investigational Site
  • 9.159.1123 Boehringer Ingelheim Investigational Site
  • 9.159.1140 Boehringer Ingelheim Investigational Site
  • 9.159.1207 Boehringer Ingelheim Investigational Site
  • 9.159.1004 Boehringer Ingelheim Investigational Site
  • 9.159.1006 Boehringer Ingelheim Investigational Site
  • 9.159.1154 Boehringer Ingelheim Investigational Site
  • 9.159.1213 Boehringer Ingelheim Investigational Site
  • 9.159.1075 Boehringer Ingelheim Investigational Site
  • 9.159.1219 Boehringer Ingelheim Investigational Site
  • 9.159.1155 Boehringer Ingelheim Investigational Site
  • 9.159.1197 Boehringer Ingelheim Investigational Site
  • 9.159.1020 Boehringer Ingelheim Investigational Site
  • 9.159.1023 Boehringer Ingelheim Investigational Site
  • 9.159.1082 Boehringer Ingelheim Investigational Site
  • 9.159.1160 Boehringer Ingelheim Investigational Site
  • 9.159.1047 Boehringer Ingelheim Investigational Site
  • 9.159.1069 Boehringer Ingelheim Investigational Site
  • 9.159.1003 Boehringer Ingelheim Investigational Site
  • 9.159.1077 Boehringer Ingelheim Investigational Site
  • 9.159.1021 Boehringer Ingelheim Investigational Site
  • 9.159.1061 Boehringer Ingelheim Investigational Site
  • 9.159.1014 Boehringer Ingelheim Investigational Site
  • 9.159.1145 Boehringer Ingelheim Investigational Site
  • 9.159.1211 Boehringer Ingelheim Investigational Site
  • 9.159.1035 Boehringer Ingelheim Investigational Site
  • 9.159.1030 Boehringer Ingelheim Investigational Site
  • 9.159.1117 Boehringer Ingelheim Investigational Site
  • 9.159.1098 Community Healthcare Clinic Westhill Medical Specialists
  • 9.159.1331 Boehringer Ingelheim Investigational Site
  • 9.159.1333 Boehringer Ingelheim Investigational Site
  • 9.159.1334 Boehringer Ingelheim Investigational Site
  • 9.159.1335 Boehringer Ingelheim Investigational Site
  • 9.159.1336 Boehringer Ingelheim Investigational Site
  • 9.159.1332 Boehringer Ingelheim Investigational Site
  • 9.159.1342 Boehringer Ingelheim Investigational Site
  • 9.159.2444 Boehringer Ingelheim Investigational Site
  • 9.159.2449 Boehringer Ingelheim Investigational Site
  • 9.159.2448 Boehringer Ingelheim Investigational Site
  • 9.159.2450 Boehringer Ingelheim Investigational Site
  • 9.159.2452 Boehringer Ingelheim Investigational Site
  • 9.159.2451 Boehringer Ingelheim Investigational Site
  • 9.159.2443 Boehringer Ingelheim Investigational Site
  • 9.159.2447 Boehringer Ingelheim Investigational Site
  • 9.159.2445 Boehringer Ingelheim Investigational Site
  • 9.159.2446 Boehringer Ingelheim Investigational Site
  • 9.159.1515 Boehringer Ingelheim Investigational Site
  • 9.159.1519 Boehringer Ingelheim Investigational Site
  • 9.159.1517 Boehringer Ingelheim Investigational Site
  • 9.159.1516 Boehringer Ingelheim Investigational Site
  • 9.159.1518 Boehringer Ingelheim Investigational Site
  • 9.159.1520 Boehringer Ingelheim Investigational Site
  • 9.159.1521 Boehringer Ingelheim Investigational Site
  • 9.159.1553 Boehringer Ingelheim Investigational Site
  • 9.159.1543 Boehringer Ingelheim Investigational Site
  • 9.159.1552 Boehringer Ingelheim Investigational Site
  • 9.159.1546 Boehringer Ingelheim Investigational Site
  • 9.159.1547 Boehringer Ingelheim Investigational Site
  • 9.159.1550 Boehringer Ingelheim Investigational Site
  • 9.159.1549 Boehringer Ingelheim Investigational Site
  • 9.159.1555 Boehringer Ingelheim Investigational Site
  • 9.159.1554 Boehringer Ingelheim Investigational Site
  • 9.159.1544 Boehringer Ingelheim Investigational Site
  • 9.159.1548 Boehringer Ingelheim Investigational Site
  • 9.159.1556 Boehringer Ingelheim Investigational Site
  • 9.159.1545 Boehringer Ingelheim Investigational Site
  • 9.159.1551 Boehringer Ingelheim Investigational Site
  • 9.159.2869 Complexo Hospitalar Universitario Prof Edgard Santos
  • 9.159.2853 Boehringer Ingelheim Investigational Site
  • 9.159.1397 Foothills Medical Centre
  • 9.159.1382 Boehringer Ingelheim Investigational Site
  • 9.159.1390 Boehringer Ingelheim Investigational Site
  • 9.159.1370 Boehringer Ingelheim Investigational Site
  • 9.159.1368 Boehringer Ingelheim Investigational Site
  • 9.159.1376 Boehringer Ingelheim Investigational Site
  • 9.159.1387 Boehringer Ingelheim Investigational Site
  • 9.159.1377 Boehringer Ingelheim Investigational Site
  • 9.159.1355 Boehringer Ingelheim Investigational Site
  • 9.159.1394 Boehringer Ingelheim Investigational Site
  • 9.159.1356 Boehringer Ingelheim Investigational Site
  • 9.159.1392 Boehringer Ingelheim Investigational Site
  • 9.159.1385 Boehringer Ingelheim Investigational Site
  • 9.159.1373 Boehringer Ingelheim Investigational Site
  • 9.159.1393 Boehringer Ingelheim Investigational Site
  • 9.159.1395 Boehringer Ingelheim Investigational Site
  • 9.159.1360 Boehringer Ingelheim Investigational Site
  • 9.159.1367 Boehringer Ingelheim Investigational Site
  • 9.159.1384 Boehringer Ingelheim Investigational Site
  • 9.159.1380 Boehringer Ingelheim Investigational Site
  • 9.159.1378 Boehringer Ingelheim Investigational Site
  • 9.159.1381 Ottawa Hospital General Campus
  • 9.159.1366 Boehringer Ingelheim Investigational Site
  • 9.159.1365 Boehringer Ingelheim Investigational Site
  • 9.159.1375 Boehringer Ingelheim Investigational Site
  • 9.159.1391 Boehringer Ingelheim Investigational Site
  • 9.159.1369 Boehringer Ingelheim Investigational Site
  • 9.159.1357 Boehringer Ingelheim Investigational Site
  • 9.159.1379 Boehringer Ingelheim Investigational Site
  • 9.159.1383 Boehringer Ingelheim Investigational Site
  • 9.159.1363 Boehringer Ingelheim Investigational Site
  • 9.159.1359 Boehringer Ingelheim Investigational Site
  • 9.159.1361 Boehringer Ingelheim Investigational Site
  • 9.159.1362 Boehringer Ingelheim Investigational Site
  • 9.159.1371 Boehringer Ingelheim Investigational Site
  • 9.159.1374 Boehringer Ingelheim Investigational Site
  • 9.159.1388 Boehringer Ingelheim Investigational Site
  • 9.159.1372 Boehringer Ingelheim Investigational Site
  • 9.159.1358 Boehringer Ingelheim Investigational Site
  • 9.159.1364 Boehringer Ingelheim Investigational Site
  • 9.159.1389 Boehringer Ingelheim Investigational Site
  • 9.159.1396 Boehringer Ingelheim Investigational Site
  • 9.159.2490 Boehringer Ingelheim Investigational Site
  • 9.159.2491 Boehringer Ingelheim Investigational Site
  • 9.159.2492 Boehringer Ingelheim Investigational Site
  • 9.159.2493 Boehringer Ingelheim Investigational Site
  • 9.159.2494 Boehringer Ingelheim Investigational Site
  • 9.159.2495 Boehringer Ingelheim Investigational Site
  • 9.159.2496 Boehringer Ingelheim Investigational Site
  • 9.159.2503 Boehringer Ingelheim Investigational Site
  • 9.159.2500 Boehringer Ingelheim Investigational Site
  • 9.159.2513 Boehringer Ingelheim Investigational Site
  • 9.159.2512 Boehringer Ingelheim Investigational Site
  • 9.159.2507 Boehringer Ingelheim Investigational Site
  • 9.159.2510 Boehringer Ingelheim Investigational Site
  • 9.159.2509 Boehringer Ingelheim Investigational Site
  • 9.159.2518 Boehringer Ingelheim Investigational Site
  • 9.159.2521 Boehringer Ingelheim Investigational Site
  • 9.159.2502 Boehringer Ingelheim Investigational Site
  • 9.159.2504 Boehringer Ingelheim Investigational Site
  • 9.159.2505 Boehringer Ingelheim Investigational Site
  • 9.159.2506 Boehringer Ingelheim Investigational Site
  • 9.159.2517 Boehringer Ingelheim Investigational Site
  • 9.159.2519 Boehringer Ingelheim Investigational Site
  • 9.159.2520 Boehringer Ingelheim Investigational Site
  • 9.159.2483 Boehringer Ingelheim Investigational Site
  • 9.159.2484 Boehringer Ingelheim Investigational Site
  • 9.159.2485 Boehringer Ingelheim Investigational Site
  • 9.159.2486 Boehringer Ingelheim Investigational Site
  • 9.159.2487 Boehringer Ingelheim Investigational Site
  • 9.159.2488 Boehringer Ingelheim Investigational Site
  • 9.159.2489 Boehringer Ingelheim Investigational Site
  • 9.159.2516 Boehringer Ingelheim Investigational Site
  • 9.159.2497 Boehringer Ingelheim Investigational Site
  • 9.159.2501 Boehringer Ingelheim Investigational Site
  • 9.159.2498 Boehringer Ingelheim Investigational Site
  • 9.159.2499 Boehringer Ingelheim Investigational Site
  • 9.159.2515 Boehringer Ingelheim Investigational Site
  • 9.159.2514 Boehringer Ingelheim Investigational Site
  • 9.159.2511 Boehringer Ingelheim Investigational Site
  • 9.159.1636 Boehringer Ingelheim Investigational Site
  • 9.159.1635 Boehringer Ingelheim Investigational Site
  • 9.159.1639 Boehringer Ingelheim Investigational Site
  • 9.159.1634 Boehringer Ingelheim Investigational Site
  • 9.159.1637 Boehringer Ingelheim Investigational Site
  • 9.159.1640 Boehringer Ingelheim Investigational Site
  • 9.159.1638 Boehringer Ingelheim Investigational Site
  • 9.159.1633 Boehringer Ingelheim Investigational Site
  • 9.159.1631 Boehringer Ingelheim Investigational Site
  • 9.159.1632 Boehringer Ingelheim Investigational Site
  • 9.159.2181 Boehringer Ingelheim Investigational Site
  • 9.159.1655 Boehringer Ingelheim Investigational Site
  • 9.159.1658 Boehringer Ingelheim Investigational Site
  • 9.159.1659 Boehringer Ingelheim Investigational Site
  • 9.159.1656 Boehringer Ingelheim Investigational Site
  • 9.159.1657 Boehringer Ingelheim Investigational Site
  • 9.159.1680 Boehringer Ingelheim Investigational Site
  • 9.159.1683 Boehringer Ingelheim Investigational Site
  • 9.159.1681 Boehringer Ingelheim Investigational Site
  • 9.159.1679 Boehringer Ingelheim Investigational Site
  • 9.159.1685 Boehringer Ingelheim Investigational Site
  • 9.159.1682 Boehringer Ingelheim Investigational Site
  • 9.159.1684 Boehringer Ingelheim Investigational Site
  • 9.159.1713 Boehringer Ingelheim Investigational Site
  • 9.159.1736 Boehringer Ingelheim Investigational Site
  • 9.159.1732 Boehringer Ingelheim Investigational Site
  • 9.159.1726 Boehringer Ingelheim Investigational Site
  • 9.159.1723 Boehringer Ingelheim Investigational Site
  • 9.159.1728 Boehringer Ingelheim Investigational Site
  • 9.159.1707 Boehringer Ingelheim Investigational Site
  • 9.159.1738 Boehringer Ingelheim Investigational Site
  • 9.159.1720 Boehringer Ingelheim Investigational Site
  • 9.159.1722 Boehringer Ingelheim Investigational Site
  • 9.159.1739 Boehringer Ingelheim Investigational Site
  • 9.159.1724 Boehringer Ingelheim Investigational Site
  • 9.159.1734 Boehringer Ingelheim Investigational Site
  • 9.159.1730 Boehringer Ingelheim Investigational Site
  • 9.159.1737 Boehringer Ingelheim Investigational Site
  • 9.159.1717 Boehringer Ingelheim Investigational Site
  • 9.159.1735 Boehringer Ingelheim Investigational Site
  • 9.159.1712 Boehringer Ingelheim Investigational Site
  • 9.159.1710 Boehringer Ingelheim Investigational Site
  • 9.159.1709 Boehringer Ingelheim Investigational Site
  • 9.159.1716 Boehringer Ingelheim Investigational Site
  • 9.159.1718 Boehringer Ingelheim Investigational Site
  • 9.159.1725 Boehringer Ingelheim Investigational Site
  • 9.159.1729 Boehringer Ingelheim Investigational Site
  • 9.159.1727 Boehringer Ingelheim Investigational Site
  • 9.159.1711 Boehringer Ingelheim Investigational Site
  • 9.159.1719 Boehringer Ingelheim Investigational Site
  • 9.159.1731 Boehringer Ingelheim Investigational Site
  • 9.159.1708 Boehringer Ingelheim Investigational Site
  • 9.159.1715 Boehringer Ingelheim Investigational Site
  • 9.159.1714 Boehringer Ingelheim Investigational Site
  • 9.159.1733 Boehringer Ingelheim Investigational Site
  • 9.159.1721 Boehringer Ingelheim Investigational Site
  • 9.159.1826 Boehringer Ingelheim Investigational Site
  • 9.159.1819 Boehringer Ingelheim Investigational Site
  • 9.159.1820 Boehringer Ingelheim Investigational Site
  • 9.159.1821 Boehringer Ingelheim Investigational Site
  • 9.159.1825 Boehringer Ingelheim Investigational Site
  • 9.159.1824 Boehringer Ingelheim Investigational Site
  • 9.159.2713 Boehringer Ingelheim Investigational Site
  • 9.159.2714 Boehringer Ingelheim Investigational Site
  • 9.159.2605 Boehringer Ingelheim Investigational Site
  • 9.159.2603 Boehringer Ingelheim Investigational Site
  • 9.159.2620 Boehringer Ingelheim Investigational Site
  • 9.159.2616 Boehringer Ingelheim Investigational Site
  • 9.159.2618 Boehringer Ingelheim Investigational Site
  • 9.159.2604 Boehringer Ingelheim Investigational Site
  • 9.159.2619 Boehringer Ingelheim Investigational Site
  • 9.159.2625 Boehringer Ingelheim Investigational Site
  • 9.159.2606 Boehringer Ingelheim Investigational Site
  • 9.159.2607 Boehringer Ingelheim Investigational Site
  • 9.159.2624 Boehringer Ingelheim Investigational Site
  • 9.159.2630 Boehringer Ingelheim Investigational Site
  • 9.159.2632 Boehringer Ingelheim Investigational Site
  • 9.159.2610 Boehringer Ingelheim Investigational Site
  • 9.159.2615 Boehringer Ingelheim Investigational Site
  • 9.159.2617 Boehringer Ingelheim Investigational Site
  • 9.159.2612 Boehringer Ingelheim Investigational Site
  • 9.159.2621 Boehringer Ingelheim Investigational Site
  • 9.159.2613 Boehringer Ingelheim Investigational Site
  • 9.159.2614 Boehringer Ingelheim Investigational Site
  • 9.159.2611 Boehringer Ingelheim Investigational Site
  • 9.159.2628 Boehringer Ingelheim Investigational Site
  • 9.159.2629 Boehringer Ingelheim Investigational Site
  • 9.159.2623 Boehringer Ingelheim Investigational Site
  • 9.159.2609 Boehringer Ingelheim Investigational Site
  • 9.159.2622 Boehringer Ingelheim Investigational Site
  • 9.159.2627 Boehringer Ingelheim Investigational Site
  • 9.159.2626 Boehringer Ingelheim Investigational Site
  • 9.159.2631 Boehringer Ingelheim Investigational Site
  • 9.159.2608 Boehringer Ingelheim Investigational Site
  • 9.159.1851 Boehringer Ingelheim Investigational Site
  • 9.159.1852 Boehringer Ingelheim Investigational Site
  • 9.159.2729 Barzilai Medical Center
  • 9.159.2721 Neurology Unit
  • 9.159.2724 Rambam Medical Center, Tel-Aviv Medical
  • 9.159.2723 Boehringer Ingelheim Investigational Site
  • 9.159.2727 Western Galilee Hospital
  • 9.159.2722 Neurology Unit
  • 9.159.2726 Sheba Medical Center
  • 9.159.2725 Tel Aviv Medical Center
  • 9.159.1875 Università degli Studi di Ancona
  • 9.159.1882 Ospedale Brotzu
  • 9.159.1883 Azienda Ospedaliera S. Anna
  • 9.159.1871 Azienda Ospedaliera "Careggi"
  • 9.159.1869 Università degli Studi di Genova
  • 9.159.1870 ASL No. 5 di Jesi
  • 9.159.1865 Ospedale Regionale "S. Salvatore"
  • 9.159.1866 Ospedale S. Raffaele
  • 9.159.1873 Istituto Scientifico "S. Luca"
  • 9.159.1884 Ospedale S. Carlo Borromeo"
  • 9.159.1868 Ospedale "S. Maria di Loreto Mare"
  • 9.159.1876 Azienda Ospedaliera di Padova -Policlinico Universitario
  • 9.159.1874 Ospedale Civico - ARNAS
  • 9.159.1872 Neuromed IRCCS
  • 9.159.1879 Policlinico S. Andrea
  • 9.159.1881 Università "La Sapienza"
  • 9.159.1877 Azienda Ospedaliera Umberto I
  • 9.159.1878 Azienda Ospedaliera "Santo Maria"
  • 9.159.1864 Azienda Ospedaliera "S. Giovanni Battista"
  • 9.159.1863 Ospedale di Cattinara
  • 9.159.1867 Presidio Ospedaliero G.Jazzolino
  • 9.159.1880 Ospedale Civile
  • 9.159.2964 Boehringer Ingelheim Investigational Site
  • 9.159.2958 Boehringer Ingelheim Investigational Site
  • 9.159.2970 Boehringer Ingelheim Investigational Site
  • 9.159.2965 Boehringer Ingelheim Investigational Site
  • 9.159.2968 Boehringer Ingelheim Investigational Site
  • 9.159.2951 Boehringer Ingelheim Investigational Site
  • 9.159.2959 Boehringer Ingelheim Investigational Site
  • 9.159.2944 Boehringer Ingelheim Investigational Site
  • 9.159.2947 Boehringer Ingelheim Investigational Site
  • 9.159.2954 Boehringer Ingelheim Investigational Site
  • 9.159.2942 Boehringer Ingelheim Investigational Site
  • 9.159.2948 Boehringer Ingelheim Investigational Site
  • 9.159.2957 Boehringer Ingelheim Investigational Site
  • 9.159.2940 Boehringer Ingelheim Investigational Site
  • 9.159.2973 Boehringer Ingelheim Investigational Site
  • 9.159.2949 Boehringer Ingelheim Investigational Site
  • 9.159.2953 Boehringer Ingelheim Investigational Site
  • 9.159.2943 Boehringer Ingelheim Investigational Site
  • 9.159.2963 Boehringer Ingelheim Investigational Site
  • 9.159.2933 Boehringer Ingelheim Investigational Site
  • 9.159.2955 Boehringer Ingelheim Investigational Site
  • 9.159.2938 Boehringer Ingelheim Investigational Site
  • 9.159.2967 Boehringer Ingelheim Investigational Site
  • 9.159.2969 Boehringer Ingelheim Investigational Site
  • 9.159.2952 Boehringer Ingelheim Investigational Site
  • 9.159.2961 Boehringer Ingelheim Investigational Site
  • 9.159.2934 Boehringer Ingelheim Investigational Site
  • 9.159.2971 Boehringer Ingelheim Investigational Site
  • 9.159.2962 Boehringer Ingelheim Investigational Site
  • 9.159.2939 Boehringer Ingelheim Investigational Site
  • 9.159.2956 Boehringer Ingelheim Investigational Site
  • 9.159.2941 Boehringer Ingelheim Investigational Site
  • 9.159.2945 Boehringer Ingelheim Investigational Site
  • 9.159.2937 Boehringer Ingelheim Investigational Site
  • 9.159.2966 Boehringer Ingelheim Investigational Site
  • 9.159.2936 Boehringer Ingelheim Investigational Site
  • 9.159.2946 Boehringer Ingelheim Investigational Site
  • 9.159.2935 Boehringer Ingelheim Investigational Site
  • 9.159.2950 Boehringer Ingelheim Investigational Site
  • 9.159.2972 Boehringer Ingelheim Investigational Site
  • 9.159.1593 Boehringer Ingelheim Investigational Site
  • 9.159.1595 Boehringer Ingelheim Investigational Site
  • 9.159.1592 Boehringer Ingelheim Investigational Site
  • 9.159.1591 Boehringer Ingelheim Investigational Site
  • 9.159.1594 Boehringer Ingelheim Investigational Site
  • 9.159.1597 Boehringer Ingelheim Investigational Site
  • 9.159.1596 Boehringer Ingelheim Investigational Site
  • 9.159.2707 Boehringer Ingelheim Investigational Site
  • 9.159.2706 Boehringer Ingelheim Investigational Site
  • 9.159.2765 Boehringer Ingelheim Investigational Site
  • 9.159.1960 Jeroen Bosch Ziekenhuis
  • 9.159.1945 Medisch Centrum Alkmaar
  • 9.159.1963 Polikliniek Neurologie
  • 9.159.1949 Ziekenhuis Gooi-Noord
  • 9.159.1962 Locatie Molengracht
  • 9.159.1950 HagaZiekenhuis
  • 9.159.1959 Catharina Ziekenhuis
  • 9.159.1946 Scheper Ziekenhuis
  • 9.159.1958 Medisch Spectrum Twente
  • 9.159.1943 Umcg
  • 9.159.1961 Lokatie Van Swieten
  • 9.159.1953 Atrium Medisch Centrum
  • 9.159.1955 Elkerliek Ziekenhuis
  • 9.159.1951 Ziekenhuisgroep Twente
  • 9.159.1948 Medisch Centrum Leeuwarden
  • 9.159.1952 Rijnland Ziekenhuis
  • 9.159.1947 Sint Antonius Ziekenhuis
  • 9.159.1964 Canisius-Wilhelmina ziekenhuis
  • 9.159.1956 TweeSteden Ziekenhuis Tilburg
  • 9.159.1957 Sint Elisabeth Ziekenhuis
  • 9.159.1944 Máxima Medisch Centrum
  • 9.159.1954 St. Jans Gasthuis
  • 9.159.2029 Boehringer Ingelheim Investigational Site
  • 9.159.2028 Boehringer Ingelheim Investigational Site
  • 9.159.2027 Boehringer Ingelheim Investigational Site
  • 9.159.2040 Hospital Fernando Fonseca
  • 9.159.2039 Centro Hospitalar e Universitário de Coimbra, EPE
  • 9.159.2041 Centro Hospitalar de Lisboa Norte
  • 9.159.2042 Centro Hospitalar do Porto
  • 9.159.2114 Boehringer Ingelheim Investigational Site
  • 9.159.2102 Boehringer Ingelheim Investigational Site
  • 9.159.2117 Boehringer Ingelheim Investigational Site
  • 9.159.2107 Boehringer Ingelheim Investigational Site
  • 9.159.2116 Boehringer Ingelheim Investigational Site
  • 9.159.2079 Boehringer Ingelheim Investigational Site
  • 9.159.2080 Boehringer Ingelheim Investigational Site
  • 9.159.2081 Boehringer Ingelheim Investigational Site
  • 9.159.2082 Boehringer Ingelheim Investigational Site
  • 9.159.2083 Boehringer Ingelheim Investigational Site
  • 9.159.2084 Boehringer Ingelheim Investigational Site
  • 9.159.2085 Boehringer Ingelheim Investigational Site
  • 9.159.2087 Boehringer Ingelheim Investigational Site
  • 9.159.2088 Boehringer Ingelheim Investigational Site
  • 9.159.2089 Boehringer Ingelheim Investigational Site
  • 9.159.2090 Boehringer Ingelheim Investigational Site
  • 9.159.2091 Boehringer Ingelheim Investigational Site
  • 9.159.2092 Boehringer Ingelheim Investigational Site
  • 9.159.2093 Boehringer Ingelheim Investigational Site
  • 9.159.2095 Boehringer Ingelheim Investigational Site
  • 9.159.2098 Boehringer Ingelheim Investigational Site
  • 9.159.2101 Boehringer Ingelheim Investigational Site
  • 9.159.2105 Boehringer Ingelheim Investigational Site
  • 9.159.2115 Boehringer Ingelheim Investigational Site
  • 9.159.2119 Boehringer Ingelheim Investigational Site
  • 9.159.2111 Boehringer Ingelheim Investigational Site
  • 9.159.2106 Boehringer Ingelheim Investigational Site
  • 9.159.2108 Boehringer Ingelheim Investigational Site
  • 9.159.2109 Boehringer Ingelheim Investigational Site
  • 9.159.2110 Boehringer Ingelheim Investigational Site
  • 9.159.2118 Boehringer Ingelheim Investigational Site
  • 9.159.2086 Boehringer Ingelheim Investigational Site
  • 9.159.2094 Boehringer Ingelheim Investigational Site
  • 9.159.2097 Boehringer Ingelheim Investigational Site
  • 9.159.2099 Boehringer Ingelheim Investigational Site
  • 9.159.2100 Boehringer Ingelheim Investigational Site
  • 9.159.2120 Boehringer Ingelheim Investigational Site
  • 9.159.2112 Boehringer Ingelheim Investigational Site
  • 9.159.2113 Boehringer Ingelheim Investigational Site
  • 9.159.2104 Boehringer Ingelheim Investigational Site
  • 9.159.2103 Boehringer Ingelheim Investigational Site
  • 9.159.2703 Boehringer Ingelheim Investigational Site
  • 9.159.2704 Boehringer Ingelheim Investigational Site
  • 9.159.2705 Boehringer Ingelheim Investigational Site
  • 9.159.2060 Boehringer Ingelheim Investigational Site
  • 9.159.2056 Boehringer Ingelheim Investigational Site
  • 9.159.2057 Boehringer Ingelheim Investigational Site
  • 9.159.2055 Boehringer Ingelheim Investigational Site
  • 9.159.2061 Boehringer Ingelheim Investigational Site
  • 9.159.2058 Boehringer Ingelheim Investigational Site
  • 9.159.2059 Boehringer Ingelheim Investigational Site
  • 9.159.2179 Boehringer Ingelheim Investigational Site
  • 9.159.2177 Boehringer Ingelheim Investigational Site
  • 9.159.2178 Boehringer Ingelheim Investigational Site
  • 9.159.2175 Boehringer Ingelheim Investigational Site
  • 9.159.2176 Boehringer Ingelheim Investigational Site
  • 9.159.2180 Boehringer Ingelheim Investigational Site
  • 9.159.2223 Boehringer Ingelheim Investigational Site
  • 9.159.2209 Boehringer Ingelheim Investigational Site
  • 9.159.2204 Boehringer Ingelheim Investigational Site
  • 9.159.2205 Boehringer Ingelheim Investigational Site
  • 9.159.2728 Neurology Unit
  • 9.159.2210 Boehringer Ingelheim Investigational Site
  • 9.159.2206 Boehringer Ingelheim Investigational Site
  • 9.159.2211 Boehringer Ingelheim Investigational Site
  • 9.159.2216 Boehringer Ingelheim Investigational Site
  • 9.159.2215 Boehringer Ingelheim Investigational Site
  • 9.159.2203 Boehringer Ingelheim Investigational Site
  • 9.159.2212 Boehringer Ingelheim Investigational Site
  • 9.159.2213 Boehringer Ingelheim Investigational Site
  • 9.159.2222 Boehringer Ingelheim Investigational Site
  • 9.159.2225 Boehringer Ingelheim Investigational Site
  • 9.159.2207 Boehringer Ingelheim Investigational Site
  • 9.159.2214 Boehringer Ingelheim Investigational Site
  • 9.159.2224 Boehringer Ingelheim Investigational Site
  • 9.159.2208 Boehringer Ingelheim Investigational Site
  • 9.159.2250 Boehringer Ingelheim Investigational Site
  • 9.159.2253 Boehringer Ingelheim Investigational Site
  • 9.159.2248 Boehringer Ingelheim Investigational Site
  • 9.159.2249 Boehringer Ingelheim Investigational Site
  • 9.159.2251 Boehringer Ingelheim Investigational Site
  • 9.159.2244 Boehringer Ingelheim Investigational Site
  • 9.159.2245 Boehringer Ingelheim Investigational Site
  • 9.159.2246 Boehringer Ingelheim Investigational Site
  • 9.159.2247 Boehringer Ingelheim Investigational Site
  • 9.159.2252 Boehringer Ingelheim Investigational Site
  • 9.159.2254 Boehringer Ingelheim Investigational Site
  • 9.159.2243 Boehringer Ingelheim Investigational Site
  • 9.159.2797 Boehringer Ingelheim Investigational Site
  • 9.159.2798 Boehringer Ingelheim Investigational Site
  • 9.159.2799 Boehringer Ingelheim Investigational Site
  • 9.159.2800 Boehringer Ingelheim Investigational Site
  • 9.159.2801 Boehringer Ingelheim Investigational Site
  • 9.159.2830 Boehringer Ingelheim Investigational Site
  • 9.159.2829 Boehringer Ingelheim Investigational Site
  • 9.159.2831 Boehringer Ingelheim Investigational Site
  • 9.159.2827 Boehringer Ingelheim Investigational Site
  • 9.159.2825 Boehringer Ingelheim Investigational Site
  • 9.159.2826 Boehringer Ingelheim Investigational Site
  • 9.159.2828 Dkuz Eylul Universitesi Tip Fakultesi Noroloji A.B.D.
  • 9.159.2387 Boehringer Ingelheim Investigational Site
  • 9.159.2384 Boehringer Ingelheim Investigational Site
  • 9.159.2385 Boehringer Ingelheim Investigational Site
  • 9.159.2386 Boehringer Ingelheim Investigational Site
  • 9.159.2392 Boehringer Ingelheim Investigational Site
  • 9.159.2379 Boehringer Ingelheim Investigational Site
  • 9.159.2380 Boehringer Ingelheim Investigational Site
  • 9.159.2382 Boehringer Ingelheim Investigational Site
  • 9.159.2389 Boehringer Ingelheim Investigational Site
  • 9.159.2390 Boehringer Ingelheim Investigational Site
  • 9.159.2391 Boehringer Ingelheim Investigational Site
  • 9.159.2388 Boehringer Ingelheim Investigational Site
  • 9.159.2304 Boehringer Ingelheim Investigational Site
  • 9.159.2297 Boehringer Ingelheim Investigational Site
  • 9.159.2299 Boehringer Ingelheim Investigational Site
  • 9.159.2301 Boehringer Ingelheim Investigational Site
  • 9.159.2298 Boehringer Ingelheim Investigational Site
  • 9.159.2307 Boehringer Ingelheim Investigational Site
  • 9.159.2296 Boehringer Ingelheim Investigational Site
  • 9.159.2300 Boehringer Ingelheim Investigational Site
  • 9.159.2287 Boehringer Ingelheim Investigational Site
  • 9.159.2303 Boehringer Ingelheim Investigational Site
  • 9.159.2308 Boehringer Ingelheim Investigational Site
  • 9.159.2295 Boehringer Ingelheim Investigational Site
  • 9.159.2286 Boehringer Ingelheim Investigational Site
  • 9.159.2293 Boehringer Ingelheim Investigational Site
  • 9.159.2294 Boehringer Ingelheim Investigational Site
  • 9.159.2305 Boehringer Ingelheim Investigational Site
  • 9.159.2290 Boehringer Ingelheim Investigational Site
  • 9.159.2288 Boehringer Ingelheim Investigational Site
  • 9.159.2285 Boehringer Ingelheim Investigational Site
  • 9.159.2284 Boehringer Ingelheim Investigational Site
  • 9.159.2283 Boehringer Ingelheim Investigational Site
  • 9.159.2302 Boehringer Ingelheim Investigational Site
  • 9.159.2292 Boehringer Ingelheim Investigational Site
  • 9.159.2289 Boehringer Ingelheim Investigational Site
  • 9.159.2306 Boehringer Ingelheim Investigational Site
  • 9.159.2291 Boehringer Ingelheim Investigational Site

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Placebo Comparator

Placebo Comparator

Placebo Comparator

Arm Label

Aggrenox, Clopidogrel placebo, Micardis

Aggrenox placebo, clopidogrel,, Micardis

Aggrenox, clop placebo, micardis placebo

Aggrenox plcebo, clop, micardis placebo

Arm Description

Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis (80mg) qd

Clopidogrel (75mg) qd; Aggrenox placebo bid, Micardis (80mg) qd

Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis placebo qd

Clopidogrel (75mg) qd, Aggrenox placebo bid, Micardis placebo qd.

Outcomes

Primary Outcome Measures

Number of Patients With First Recurrent Stroke of Any Type, Fatal or Nonfatal (Antiplatelet Comparison Only)
Number of Patients With First Recurrent Stroke of Any Type, Fatal or Nonfatal (Telmisartan vs. Placebo Only)

Secondary Outcome Measures

Composite Outcome of Stroke, Myocardial Infarction (MI), or Vascular Death (Antiplatelet Comparison Only)
Number of patients with any of stroke, myocardial infarction, vascular death
Composite Outcome of Stroke, Myocardial Infarction, Vascular Death, or New or Worsening Congestive Heart Failure (CHF) (Telmisartan vs. Placebo Only)
Number of patients with any of stroke, myocardial infarction, vascular death, or new or worsening congestive heart failure
Number of Patients With New Onset of Diabetes (Telmisartan vs. Placebo Only)

Full Information

First Posted
September 9, 2005
Last Updated
April 22, 2014
Sponsor
Boehringer Ingelheim
Collaborators
GlaxoSmithKline, Bayer
search

1. Study Identification

Unique Protocol Identification Number
NCT00153062
Brief Title
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Official Title
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
August 2003 (undefined)
Primary Completion Date
April 2008 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Boehringer Ingelheim
Collaborators
GlaxoSmithKline, Bayer

4. Oversight

5. Study Description

Brief Summary
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
20332 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aggrenox, Clopidogrel placebo, Micardis
Arm Type
Placebo Comparator
Arm Description
Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis (80mg) qd
Arm Title
Aggrenox placebo, clopidogrel,, Micardis
Arm Type
Placebo Comparator
Arm Description
Clopidogrel (75mg) qd; Aggrenox placebo bid, Micardis (80mg) qd
Arm Title
Aggrenox, clop placebo, micardis placebo
Arm Type
Placebo Comparator
Arm Description
Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis placebo qd
Arm Title
Aggrenox plcebo, clop, micardis placebo
Arm Type
Placebo Comparator
Arm Description
Clopidogrel (75mg) qd, Aggrenox placebo bid, Micardis placebo qd.
Intervention Type
Drug
Intervention Name(s)
Aggrenox
Intervention Description
25mg aspirin, 200 mg dipyridamole
Intervention Type
Drug
Intervention Name(s)
Aggrenox
Intervention Description
25mg aspirin, 200 mg dipyridamole
Intervention Type
Drug
Intervention Name(s)
Clopidogrel placebo
Intervention Description
placebo
Intervention Type
Drug
Intervention Name(s)
Clopidogrel placebo
Intervention Description
placebo
Intervention Type
Drug
Intervention Name(s)
Micardis
Intervention Description
80 mg micardis
Intervention Type
Drug
Intervention Name(s)
Micardis
Intervention Description
80 mg micardis
Intervention Type
Drug
Intervention Name(s)
Aggrenox placebo
Intervention Description
placebo
Intervention Type
Drug
Intervention Name(s)
Aggrenox placebo
Intervention Description
placebo
Intervention Type
Drug
Intervention Name(s)
Clopidogrel
Intervention Description
75 mg clopidogrel
Intervention Type
Drug
Intervention Name(s)
Clopidogrel
Intervention Description
75 mg clopidogrel
Intervention Type
Drug
Intervention Name(s)
Micardis placebo
Intervention Description
placebo
Intervention Type
Drug
Intervention Name(s)
Micardis placebo
Intervention Description
placebo
Primary Outcome Measure Information:
Title
Number of Patients With First Recurrent Stroke of Any Type, Fatal or Nonfatal (Antiplatelet Comparison Only)
Time Frame
time since randomization; follow-up period is 1.5 to 4.4 years
Title
Number of Patients With First Recurrent Stroke of Any Type, Fatal or Nonfatal (Telmisartan vs. Placebo Only)
Time Frame
time since randomization; follow-up period is 1.5 to 4.4 years
Secondary Outcome Measure Information:
Title
Composite Outcome of Stroke, Myocardial Infarction (MI), or Vascular Death (Antiplatelet Comparison Only)
Description
Number of patients with any of stroke, myocardial infarction, vascular death
Time Frame
time since randomization; follow-up period is 1.5 to 4.4 years
Title
Composite Outcome of Stroke, Myocardial Infarction, Vascular Death, or New or Worsening Congestive Heart Failure (CHF) (Telmisartan vs. Placebo Only)
Description
Number of patients with any of stroke, myocardial infarction, vascular death, or new or worsening congestive heart failure
Time Frame
time since randomization; follow-up period is 1.5 to 4.4 years
Title
Number of Patients With New Onset of Diabetes (Telmisartan vs. Placebo Only)
Time Frame
Randomization to final patient contact

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: Male or female subjects 55 year or older who have suffered an ischemic stroke within the past 90 days and who meet all other inclusion criteria. Include also patients of ages 50 - 54 years and/or 90 to 120 days after the qualifying stroke provided the patient has at least two of the following additional risk factors: Diabetes mellitus Hypertension (systolic BP ¿ 140 or diastolic BP ¿ 90) Smoker at time of qualifying stroke Obesity (BMI>30; BMI=weight (kg)/[height (m)]2) Previous vascular disease (stroke, MI, or peripheral arterial disease prior to qualifying stroke) End-organ-damage (retinopathy, LVH, or microalbuminuria) Hyperlipidemia Exclusion criteria: hemorrhagic stroke (must be ruled out by imaging);unable to give informed consent; known brain tumor, severe renal or hepatic insufficiency, current active peptic ulcer disease, severe coronary artery disease including unstable angina pectoris or an MI within the previous 3 months,or history of a hemostatic disorder or systemic bleeding ;hyperkalemia;uncorrected volume or sodium depletion; pre-stroke history of dementia;modified Rankin score greater than 4;qualifying stroke induced by surgical or cardiovascular procedure;uncontrolled hypertension at entry above 180/110 mmHg (goal BPs are lower); SBP 120 mmHg or less for hospitalized patients; currently taking an ARB and not able or willing to switch to alternative; required or planned continuing treatment with antithrombotics or anticoagulants including heparin or warfarin or non-study platelet inhibitors; syndrome of asthma, rhinitis and nasal polyps;scheduled for major surgery, carotid endarterectomy, or carotid angioplasty (4 weeks post surgery is allowed);unlikely to be released from hospital following the qualifying stroke or presence of a severe disability likely to lead to being bedridden or demented or a non-vascular disease or condition which makes it unlikely that the patient will survive to the end of the trial; history of thrombocytopenia or neutropenia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Boehringer Ingelheim
Organizational Affiliation
Boehringer Ingelheim
Official's Role
Study Chair
Facility Information:
Facility Name
9.159.1101 Boehringer Ingelheim Investigational Site
City
Birmingham
State/Province
Alabama
Country
United States
Facility Name
9.159.1173 Boehringer Ingelheim Investigational Site
City
Huntsville
State/Province
Alabama
Country
United States
Facility Name
9.159.1058 Boehringer Ingelheim Investigational Site
City
Mobile
State/Province
Alabama
Country
United States
Facility Name
9.159.1087 Boehringer Ingelheim Investigational Site
City
Montgomery
State/Province
Alabama
Country
United States
Facility Name
9.159.1081 Boehringer Ingelheim Investigational Site
City
Northport
State/Province
Alabama
Country
United States
Facility Name
9.159.1022 Boehringer Ingelheim Investigational Site
City
Phoenix
State/Province
Arizona
Country
United States
Facility Name
9.159.1133 Boehringer Ingelheim Investigational Site
City
Phoenix
State/Province
Arizona
Country
United States
Facility Name
9.159.1149 Boehringer Ingelheim Investigational Site
City
Phoenix
State/Province
Arizona
Country
United States
Facility Name
9.159.1137 Boehringer Ingelheim Investigational Site
City
Tucson
State/Province
Arizona
Country
United States
Facility Name
9.159.1184 Boehringer Ingelheim Investigational Site
City
Fayetteville
State/Province
Arkansas
Country
United States
Facility Name
9.159.1005 Boehringer Ingelheim Investigational Site
City
Fort Smith
State/Province
Arkansas
Country
United States
Facility Name
9.159.1136 Boehringer Ingelheim Investigational Site
City
Jonesboro
State/Province
Arkansas
Country
United States
Facility Name
9.159.1062 Boehringer Ingelheim Investigational Site
City
Little Rock
State/Province
Arkansas
Country
United States
Facility Name
9.159.1040 Boehringer Ingelheim Investigational Site
City
Berkeley
State/Province
California
Country
United States
Facility Name
9.159.1180 Boehringer Ingelheim Investigational Site
City
Carmichael
State/Province
California
Country
United States
Facility Name
9.159.1114 Boehringer Ingelheim Investigational Site
City
Irvine
State/Province
California
Country
United States
Facility Name
9.159.1202 Boehringer Ingelheim Investigational Site
City
Laguna Hills
State/Province
California
Country
United States
Facility Name
9.159.1036 Boehringer Ingelheim Investigational Site
City
Los Angeles
State/Province
California
Country
United States
Facility Name
9.159.1052 Boehringer Ingelheim Investigational Site
City
Los Angeles
State/Province
California
Country
United States
Facility Name
9.159.1100 Boehringer Ingelheim Investigational Site
City
Los Angeles
State/Province
California
Country
United States
Facility Name
9.159.1111 Boehringer Ingelheim Investigational Site
City
Los Angeles
State/Province
California
Country
United States
Facility Name
9.159.1165 Boehringer Ingelheim Investigational Site
City
Los Angeles
State/Province
California
Country
United States
Facility Name
9.159.1134 Boehringer Ingelheim Investigational Site
City
Oceanside
State/Province
California
Country
United States
Facility Name
9.159.1002 Boehringer Ingelheim Investigational Site
City
Palo Alto
State/Province
California
Country
United States
Facility Name
9.159.1108 Boehringer Ingelheim Investigational Site
City
Redding
State/Province
California
Country
United States
Facility Name
9.159.1013 Boehringer Ingelheim Investigational Site
City
Sacramento
State/Province
California
Country
United States
Facility Name
9.159.1198 Boehringer Ingelheim Investigational Site
City
Sacramento
State/Province
California
Country
United States
Facility Name
9.159.1029 Boehringer Ingelheim Investigational Site
City
San Diego
State/Province
California
Country
United States
Facility Name
9.159.1185 Boehringer Ingelheim Investigational Site
City
San Francisco
State/Province
California
Country
United States
Facility Name
9.159.1218 Boehringer Ingelheim Investigational Site
City
San Jose
State/Province
California
Country
United States
Facility Name
9.159.1179 Boehringer Ingelheim Investigational Site
City
Santa Rosa
State/Province
California
Country
United States
Facility Name
9.159.1162 Boehringer Ingelheim Investigational Site
City
Sylmar
State/Province
California
Country
United States
Facility Name
9.159.1183 Boehringer Ingelheim Investigational Site
City
Torrance
State/Province
California
Country
United States
Facility Name
9.159.1205 Boehringer Ingelheim Investigational Site
City
Walnut Creek
State/Province
California
Country
United States
Facility Name
9.159.1118 Boehringer Ingelheim Investigational Site
City
Denver
State/Province
Colorado
Country
United States
Facility Name
9.159.1045 Boehringer Ingelheim Investigational Site
City
Englewood
State/Province
Colorado
Country
United States
Facility Name
9.159.1038 Boehringer Ingelheim Investigational Site
City
Danbury
State/Province
Connecticut
Country
United States
Facility Name
9.159.1196 Boehringer Ingelheim Investigational Site
City
Fairfield
State/Province
Connecticut
Country
United States
Facility Name
9.159.1018 Boehringer Ingelheim Investigational Site
City
Hartford
State/Province
Connecticut
Country
United States
Facility Name
9.159.1080 Boehringer Ingelheim Investigational Site
City
Newark
State/Province
Delaware
Country
United States
Facility Name
9.159.1120 Boehringer Ingelheim Investigational Site
City
Washington
State/Province
District of Columbia
Country
United States
Facility Name
9.159.1216 Boehringer Ingelheim Investigational Site
City
Washington
State/Province
District of Columbia
Country
United States
Facility Name
9.159.1057 Boehringer Ingelheim Investigational Site
City
Bay Pines
State/Province
Florida
Country
United States
Facility Name
9.159.1217 Boehringer Ingelheim Investigational Site
City
Boca Raton
State/Province
Florida
Country
United States
Facility Name
9.159.1096 Boehringer Ingelheim Investigational Site
City
Bradenton
State/Province
Florida
Country
United States
Facility Name
9.159.1144 Boehringer Ingelheim Investigational Site
City
Clearwater
State/Province
Florida
Country
United States
Facility Name
9.159.1007 Boehringer Ingelheim Investigational Site
City
Ft. Lauderdale
State/Province
Florida
Country
United States
Facility Name
9.159.1190 Boehringer Ingelheim Investigational Site
City
Jacksonville
State/Province
Florida
Country
United States
Facility Name
9.159.1150 Boehringer Ingelheim Investigational Site
City
Ocala
State/Province
Florida
Country
United States
Facility Name
9.159.1153 Boehringer Ingelheim Investigational Site
City
Panama City
State/Province
Florida
Country
United States
Facility Name
9.159.1041 Boehringer Ingelheim Investigational Site
City
Plantation
State/Province
Florida
Country
United States
Facility Name
9.159.1072 Boehringer Ingelheim Investigational Site
City
Port Charlotte
State/Province
Florida
Country
United States
Facility Name
9.159.1063 Boehringer Ingelheim Investigational Site
City
Sarasota
State/Province
Florida
Country
United States
Facility Name
9.159.1208 Boehringer Ingelheim Investigational Site
City
Tampa
State/Province
Florida
Country
United States
Facility Name
9.159.1049 Boehringer Ingelheim Investigational Site
City
Vero Beach
State/Province
Florida
Country
United States
Facility Name
9.159.1176 Boehringer Ingelheim Investigational Site
City
West Palm Beach
State/Province
Florida
Country
United States
Facility Name
9.159.1071 Boehringer Ingelheim Investigational Site
City
Atlanta
State/Province
Georgia
Country
United States
Facility Name
9.159.1079 Boehringer Ingelheim Investigational Site
City
Augusta
State/Province
Georgia
Country
United States
Facility Name
9.159.1181 Boehringer Ingelheim Investigational Site
City
Columbus
State/Province
Georgia
Country
United States
Facility Name
9.159.1138 Boehringer Ingelheim Investigational Site
City
Decatur
State/Province
Georgia
Country
United States
Facility Name
9.159.1070 Boehringer Ingelheim Investigational Site
City
Rome
State/Province
Georgia
Country
United States
Facility Name
9.159.1107 Boehringer Ingelheim Investigational Site
City
Savannah
State/Province
Georgia
Country
United States
Facility Name
9.159.1189 Boehringer Ingelheim Investigational Site
City
Boise
State/Province
Idaho
Country
United States
Facility Name
9.159.1026 University of Illinois
City
Chicago
State/Province
Illinois
Country
United States
Facility Name
9.159.1033 Boehringer Ingelheim Investigational Site
City
Chicago
State/Province
Illinois
Country
United States
Facility Name
9.159.1060 Boehringer Ingelheim Investigational Site
City
Chicago
State/Province
Illinois
Country
United States
Facility Name
9.159.1044 Boehringer Ingelheim Investigational Site
City
Maywood
State/Province
Illinois
Country
United States
Facility Name
9.159.1054 Boehringer Ingelheim Investigational Site
City
Palos Heights
State/Province
Illinois
Country
United States
Facility Name
9.159.1068 Boehringer Ingelheim Investigational Site
City
Park Ridge
State/Province
Illinois
Country
United States
Facility Name
9.159.1178 Boehringer Ingelheim Investigational Site
City
Peoria
State/Province
Illinois
Country
United States
Facility Name
9.159.1156 Boehringer Ingelheim Investigational Site
City
Elkhart
State/Province
Indiana
Country
United States
Facility Name
9.159.1092 Boehringer Ingelheim Investigational Site
City
South Bend
State/Province
Indiana
Country
United States
Facility Name
9.159.1027 Boehringer Ingelheim Investigational Site
City
Cedar Rapids
State/Province
Iowa
Country
United States
Facility Name
9.159.1119 Boehringer Ingelheim Investigational Site
City
Des Moines
State/Province
Iowa
Country
United States
Facility Name
9.159.1187 Boehringer Ingelheim Investigational Site
City
Des Moines
State/Province
Iowa
Country
United States
Facility Name
9.159.1059 Boehringer Ingelheim Investigational Site
City
Iowa City
State/Province
Iowa
Country
United States
Facility Name
9.159.1135 Boehringer Ingelheim Investigational Site
City
Waterloo
State/Province
Iowa
Country
United States
Facility Name
9.159.1090 Boehringer Ingelheim Investigational Site
City
Kansas City
State/Province
Kansas
Country
United States
Facility Name
9.159.1129 Central Baptis Hospital
City
Lexington
State/Province
Kentucky
Country
United States
Facility Name
9.159.1131 Boehringer Ingelheim Investigational Site
City
Lexington
State/Province
Kentucky
Country
United States
Facility Name
9.159.1206 Boehringer Ingelheim Investigational Site
City
Lexington
State/Province
Kentucky
Country
United States
Facility Name
9.159.1212 Boehringer Ingelheim Investigational Site
City
Lexington
State/Province
Kentucky
Country
United States
Facility Name
9.159.1091 Boehringer Ingelheim Investigational Site
City
Louisville
State/Province
Kentucky
Country
United States
Facility Name
9.159.1147 Boehringer Ingelheim Investigational Site
City
Louisville
State/Province
Kentucky
Country
United States
Facility Name
9.159.1106 Boehringer Ingelheim Investigational Site
City
Baton Rouge
State/Province
Louisiana
Country
United States
Facility Name
9.159.1194 Boehringer Ingelheim Investigational Site
City
Marrero
State/Province
Louisiana
Country
United States
Facility Name
9.159.1083 Boehringer Ingelheim Investigational Site
City
New Orleans
State/Province
Louisiana
Country
United States
Facility Name
9.159.1195 Boehringer Ingelheim Investigational Site
City
Shreveport
State/Province
Louisiana
Country
United States
Facility Name
9.159.1024 Boehringer Ingelheim Investigational Site
City
Baltimore
State/Province
Maryland
Country
United States
Facility Name
9.159.1055 Boehringer Ingelheim Investigational Site
City
Baltimore
State/Province
Maryland
Country
United States
Facility Name
9.159.1139 Boehringer Ingelheim Investigational Site
City
Baltimore
State/Province
Maryland
Country
United States
Facility Name
9.159.1031 Boehringer Ingelheim Investigational Site
City
Boston
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1066 Boehringer Ingelheim Investigational Site
City
Boston
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1104 Boehringer Ingelheim Investigational Site
City
Boston
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1166 Boehringer Ingelheim Investigational Site
City
Boston
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1192 Boehringer Ingelheim Investigational Site
City
South Weymouth
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1039 Boehringer Ingelheim Investigational Site
City
Worchester
State/Province
Massachusetts
Country
United States
Facility Name
9.159.1019 Boehringer Ingelheim Investigational Site
City
Detroit
State/Province
Michigan
Country
United States
Facility Name
9.159.1048 Boehringer Ingelheim Investigational Site
City
Detroit
State/Province
Michigan
Country
United States
Facility Name
9.159.1089 Boehringer Ingelheim Investigational Site
City
Detroit
State/Province
Michigan
Country
United States
Facility Name
9.159.1078 Boehringer Ingelheim Investigational Site
City
East Lansing
State/Province
Michigan
Country
United States
Facility Name
9.159.1143 Boehringer Ingelheim Investigational Site
City
Grand Rapids
State/Province
Michigan
Country
United States
Facility Name
9.159.1102 Boehringer Ingelheim Investigational Site
City
Kalamazoo
State/Province
Michigan
Country
United States
Facility Name
9.159.1011 Boehringer Ingelheim Investigational Site
City
Saginaw
State/Province
Michigan
Country
United States
Facility Name
9.159.1132 Boehringer Ingelheim Investigational Site
City
Southfield
State/Province
Michigan
Country
United States
Facility Name
9.159.1088 Boehringer Ingelheim Investigational Site
City
Duluth
State/Province
Minnesota
Country
United States
Facility Name
9.159.1158 Boehringer Ingelheim Investigational Site
City
Duluth
State/Province
Minnesota
Country
United States
Facility Name
9.159.1084 Boehringer Ingelheim Investigational Site
City
Golden Valley
State/Province
Minnesota
Country
United States
Facility Name
9.159.1097 Boehringer Ingelheim Investigational Site
City
Minneapolis
State/Province
Minnesota
Country
United States
Facility Name
9.159.1113 Boehringer Ingelheim Investigational Site
City
Minneapolis
State/Province
Minnesota
Country
United States
Facility Name
9.159.1128 St. Luke's Hospital MABSI Research
City
Kansas City
State/Province
Missouri
Country
United States
Facility Name
9.159.1172 Boehringer Ingelheim Investigational Site
City
Lees Summit
State/Province
Missouri
Country
United States
Facility Name
9.159.1174 Boehringer Ingelheim Investigational Site
City
Saint Louis
State/Province
Missouri
Country
United States
Facility Name
9.159.1009 Boehringer Ingelheim Investigational Site
City
Springfield
State/Province
Missouri
Country
United States
Facility Name
9.159.1182 Boehringer Ingelheim Investigational Site
City
St. Louis
State/Province
Missouri
Country
United States
Facility Name
9.159.1191 Boehringer Ingelheim Investigational Site
City
St. Louis
State/Province
Missouri
Country
United States
Facility Name
9.159.1146 Boehringer Ingelheim Investigational Site
City
Great Falls
State/Province
Montana
Country
United States
Facility Name
9.159.1201 Boehringer Ingelheim Investigational Site
City
Omaha
State/Province
Nebraska
Country
United States
Facility Name
9.159.1127 Boehringer Ingelheim Investigational Site
City
Las Vegas
State/Province
Nevada
Country
United States
Facility Name
9.159.1188 Boehringer Ingelheim Investigational Site
City
Reno
State/Province
Nevada
Country
United States
Facility Name
9.159.1204 Boehringer Ingelheim Investigational Site
City
Camden
State/Province
New Jersey
Country
United States
Facility Name
9.159.1203 Boehringer Ingelheim Investigational Site
City
Edison
State/Province
New Jersey
Country
United States
Facility Name
9.159.1042 Neurology Consultants of Burlington County
City
Lumberton
State/Province
New Jersey
Country
United States
Facility Name
9.159.1209 Boehringer Ingelheim Investigational Site
City
New Brunswick
State/Province
New Jersey
Country
United States
Facility Name
9.159.1125 Boehringer Ingelheim Investigational Site
City
Newark
State/Province
New Jersey
Country
United States
Facility Name
9.159.1095 Boehringer Ingelheim Investigational Site
City
Ridgewood
State/Province
New Jersey
Country
United States
Facility Name
9.159.1170 Boehringer Ingelheim Investigational Site
City
Albuquerque
State/Province
New Mexico
Country
United States
Facility Name
9.159.1086 Boehringer Ingelheim Investigational Site
City
Albany
State/Province
New York
Country
United States
Facility Name
9.159.1121 Boehringer Ingelheim Investigational Site
City
Bronx
State/Province
New York
Country
United States
Facility Name
9.159.1130 Boehringer Ingelheim Investigational Site
City
Bronx
State/Province
New York
Country
United States
Facility Name
9.159.1017 Boehringer Ingelheim Investigational Site
City
Brooklyn
State/Province
New York
Country
United States
Facility Name
9.159.1064 Boehringer Ingelheim Investigational Site
City
Brooklyn
State/Province
New York
Country
United States
Facility Name
9.159.1186 Boehringer Ingelheim Investigational Site
City
Brooklyn
State/Province
New York
Country
United States
Facility Name
9.159.1151 Boehringer Ingelheim Investigational Site
City
Buffalo
State/Province
New York
Country
United States
Facility Name
9.159.1076 North Shore University Hospital
City
Manasset
State/Province
New York
Country
United States
Facility Name
9.159.1037 Boehringer Ingelheim Investigational Site
City
Mineola
State/Province
New York
Country
United States
Facility Name
9.159.1220 Boehringer Ingelheim Investigational Site
City
New Hyde Park
State/Province
New York
Country
United States
Facility Name
9.159.1001 Boehringer Ingelheim Investigational Site
City
New York
State/Province
New York
Country
United States
Facility Name
9.159.1116 Boehringer Ingelheim Investigational Site
City
New York
State/Province
New York
Country
United States
Facility Name
9.159.1142 Saint Luke's-Roosevelt Hospital
City
New York
State/Province
New York
Country
United States
Facility Name
9.159.1126 Boehringer Ingelheim Investigational Site
City
Schenectady
State/Province
New York
Country
United States
Facility Name
9.159.1163 Boehringer Ingelheim Investigational Site
City
Stony Brook
State/Province
New York
Country
United States
Facility Name
9.159.1169 Boehringer Ingelheim Investigational Site
City
Tonawanda
State/Province
New York
Country
United States
Facility Name
9.159.1065 Boehringer Ingelheim Investigational Site
City
White Plains
State/Province
New York
Country
United States
Facility Name
9.159.1099 Boehringer Ingelheim Investigational Site
City
Asheville
State/Province
North Carolina
Country
United States
Facility Name
9.159.1046 Boehringer Ingelheim Investigational Site
City
Chapel Hill
State/Province
North Carolina
Country
United States
Facility Name
9.159.1094 Boehringer Ingelheim Investigational Site
City
Durham
State/Province
North Carolina
Country
United States
Facility Name
9.159.1012 Boehringer Ingelheim Investigational Site
City
High Point
State/Province
North Carolina
Country
United States
Facility Name
9.159.1115
City
Wilmington
State/Province
North Carolina
Country
United States
Facility Name
9.159.1051 Boehringer Ingelheim Investigational Site
City
Winston-Salem
State/Province
North Carolina
Country
United States
Facility Name
9.159.1110 Boehringer Ingelheim Investigational Site
City
Winston-Salem
State/Province
North Carolina
Country
United States
Facility Name
9.159.1215 Boehringer Ingelheim Investigational Site
City
Bismarck
State/Province
North Dakota
Country
United States
Facility Name
9.159.1152 Boehringer Ingelheim Investigational Site
City
Fargo
State/Province
North Dakota
Country
United States
Facility Name
9.159.1159 Boehringer Ingelheim Investigational Site
City
Akron
State/Province
Ohio
Country
United States
Facility Name
9.159.1085 Boehringer Ingelheim Investigational Site
City
Canton
State/Province
Ohio
Country
United States
Facility Name
9.159.1032 Boehringer Ingelheim Investigational Site
City
Cincinnati
State/Province
Ohio
Country
United States
Facility Name
9.159.1025 Boehringer Ingelheim Investigational Site
City
Cleveland
State/Province
Ohio
Country
United States
Facility Name
9.159.1177 Boehringer Ingelheim Investigational Site
City
Cleveland
State/Province
Ohio
Country
United States
Facility Name
9.159.1008 Boehringer Ingelheim Investigational Site
City
Columbus
State/Province
Ohio
Country
United States
Facility Name
9.159.1141 Boehringer Ingelheim Investigational Site
City
Columbus
State/Province
Ohio
Country
United States
Facility Name
9.159.1053 Boehringer Ingelheim Investigational Site
City
Toledo
State/Province
Ohio
Country
United States
Facility Name
9.159.1122 Boehringer Ingelheim Investigational Site
City
Youngstown
State/Province
Ohio
Country
United States
Facility Name
9.159.1199 Boehringer Ingelheim Investigational Site
City
Oklahoma City
State/Province
Oklahoma
Country
United States
Facility Name
9.159.1010 Boehringer Ingelheim Investigational Site
City
Portland
State/Province
Oregon
Country
United States
Facility Name
9.159.1171 Boehringer Ingelheim Investigational Site
City
Abington
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1210 Boehringer Ingelheim Investigational Site
City
Allentown
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1214 Boehringer Ingelheim Investigational Site
City
Allentown
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1200 Boehringer Ingelheim Investigational Site
City
Erie
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1043 Boehringer Ingelheim Investigational Site
City
Greensburg
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1164 Boehringer Ingelheim Investigational Site
City
Hershey
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1175 Boehringer Ingelheim Investigational Site
City
Lancaster
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1016 Boehringer Ingelheim Investigational Site
City
Philadelphia
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1056 Boehringer Ingelheim Investigational Site
City
Philadelphia
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1074 Boehringer Ingelheim Investigational Site
City
Philadelphia
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1112 Boehringer Ingelheim Investigational Site
City
Pittsburgh
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1148 Boehringer Ingelheim Investigational Site
City
Upland
State/Province
Pennsylvania
Country
United States
Facility Name
9.159.1123 Boehringer Ingelheim Investigational Site
City
Providence
State/Province
Rhode Island
Country
United States
Facility Name
9.159.1140 Boehringer Ingelheim Investigational Site
City
Columbia
State/Province
South Carolina
Country
United States
Facility Name
9.159.1207 Boehringer Ingelheim Investigational Site
City
Greenville
State/Province
South Carolina
Country
United States
Facility Name
9.159.1004 Boehringer Ingelheim Investigational Site
City
Spartanberg
State/Province
South Carolina
Country
United States
Facility Name
9.159.1006 Boehringer Ingelheim Investigational Site
City
Bristol
State/Province
Tennessee
Country
United States
Facility Name
9.159.1154 Boehringer Ingelheim Investigational Site
City
Knoxville
State/Province
Tennessee
Country
United States
Facility Name
9.159.1213 Boehringer Ingelheim Investigational Site
City
Memphis
State/Province
Tennessee
Country
United States
Facility Name
9.159.1075 Boehringer Ingelheim Investigational Site
City
Nashville
State/Province
Tennessee
Country
United States
Facility Name
9.159.1219 Boehringer Ingelheim Investigational Site
City
Brownwood
State/Province
Texas
Country
United States
Facility Name
9.159.1155 Boehringer Ingelheim Investigational Site
City
Dallas
State/Province
Texas
Country
United States
Facility Name
9.159.1197 Boehringer Ingelheim Investigational Site
City
Dallas
State/Province
Texas
Country
United States
Facility Name
9.159.1020 Boehringer Ingelheim Investigational Site
City
Houston
State/Province
Texas
Country
United States
Facility Name
9.159.1023 Boehringer Ingelheim Investigational Site
City
Houston
State/Province
Texas
Country
United States
Facility Name
9.159.1082 Boehringer Ingelheim Investigational Site
City
Houston
State/Province
Texas
Country
United States
Facility Name
9.159.1160 Boehringer Ingelheim Investigational Site
City
Houston
State/Province
Texas
Country
United States
Facility Name
9.159.1047 Boehringer Ingelheim Investigational Site
City
San Antonio
State/Province
Texas
Country
United States
Facility Name
9.159.1069 Boehringer Ingelheim Investigational Site
City
Tyler
State/Province
Texas
Country
United States
Facility Name
9.159.1003 Boehringer Ingelheim Investigational Site
City
Bountiful
State/Province
Utah
Country
United States
Facility Name
9.159.1077 Boehringer Ingelheim Investigational Site
City
Newport News
State/Province
Virginia
Country
United States
Facility Name
9.159.1021 Boehringer Ingelheim Investigational Site
City
Richmond
State/Province
Virginia
Country
United States
Facility Name
9.159.1061 Boehringer Ingelheim Investigational Site
City
Salem
State/Province
Virginia
Country
United States
Facility Name
9.159.1014 Boehringer Ingelheim Investigational Site
City
Seattle
State/Province
Washington
Country
United States
Facility Name
9.159.1145 Boehringer Ingelheim Investigational Site
City
Spokane
State/Province
Washington
Country
United States
Facility Name
9.159.1211 Boehringer Ingelheim Investigational Site
City
Charleston
State/Province
West Virginia
Country
United States
Facility Name
9.159.1035 Boehringer Ingelheim Investigational Site
City
Morgantown
State/Province
West Virginia
Country
United States
Facility Name
9.159.1030 Boehringer Ingelheim Investigational Site
City
Marshfield
State/Province
Wisconsin
Country
United States
Facility Name
9.159.1117 Boehringer Ingelheim Investigational Site
City
Milwaukee
State/Province
Wisconsin
Country
United States
Facility Name
9.159.1098 Community Healthcare Clinic Westhill Medical Specialists
City
Wausau
State/Province
Wisconsin
Country
United States
Facility Name
9.159.1331 Boehringer Ingelheim Investigational Site
City
Capital Federal
Country
Argentina
Facility Name
9.159.1333 Boehringer Ingelheim Investigational Site
City
Capital Federal
Country
Argentina
Facility Name
9.159.1334 Boehringer Ingelheim Investigational Site
City
Capital Federal
Country
Argentina
Facility Name
9.159.1335 Boehringer Ingelheim Investigational Site
City
Capital Federal
Country
Argentina
Facility Name
9.159.1336 Boehringer Ingelheim Investigational Site
City
Capital Federal
Country
Argentina
Facility Name
9.159.1332 Boehringer Ingelheim Investigational Site
City
Rosario, Sta. Fe
Country
Argentina
Facility Name
9.159.1342 Boehringer Ingelheim Investigational Site
City
Santa Fe
Country
Argentina
Facility Name
9.159.2444 Boehringer Ingelheim Investigational Site
City
Gosford
State/Province
New South Wales
Country
Australia
Facility Name
9.159.2449 Boehringer Ingelheim Investigational Site
City
New Lambton
State/Province
New South Wales
Country
Australia
Facility Name
9.159.2448 Boehringer Ingelheim Investigational Site
City
Westmead
State/Province
New South Wales
Country
Australia
Facility Name
9.159.2450 Boehringer Ingelheim Investigational Site
City
Herston
State/Province
Queensland
Country
Australia
Facility Name
9.159.2452 Boehringer Ingelheim Investigational Site
City
Southport
State/Province
Queensland
Country
Australia
Facility Name
9.159.2451 Boehringer Ingelheim Investigational Site
City
Bedford Park
State/Province
South Australia
Country
Australia
Facility Name
9.159.2443 Boehringer Ingelheim Investigational Site
City
Box Hill
State/Province
Victoria
Country
Australia
Facility Name
9.159.2447 Boehringer Ingelheim Investigational Site
City
Melbourne
State/Province
Victoria
Country
Australia
Facility Name
9.159.2445 Boehringer Ingelheim Investigational Site
City
Parkville
State/Province
Victoria
Country
Australia
Facility Name
9.159.2446 Boehringer Ingelheim Investigational Site
City
West Heidelberg
State/Province
Victoria
Country
Australia
Facility Name
9.159.1515 Boehringer Ingelheim Investigational Site
City
Graz
Country
Austria
Facility Name
9.159.1519 Boehringer Ingelheim Investigational Site
City
Graz
Country
Austria
Facility Name
9.159.1517 Boehringer Ingelheim Investigational Site
City
Innsbruck
Country
Austria
Facility Name
9.159.1516 Boehringer Ingelheim Investigational Site
City
Linz
Country
Austria
Facility Name
9.159.1518 Boehringer Ingelheim Investigational Site
City
Ma.Gugging/Klosterneuburg
Country
Austria
Facility Name
9.159.1520 Boehringer Ingelheim Investigational Site
City
St. Pölten
Country
Austria
Facility Name
9.159.1521 Boehringer Ingelheim Investigational Site
City
Wien
Country
Austria
Facility Name
9.159.1553 Boehringer Ingelheim Investigational Site
City
Aalst
Country
Belgium
Facility Name
9.159.1543 Boehringer Ingelheim Investigational Site
City
Anderlecht
Country
Belgium
Facility Name
9.159.1552 Boehringer Ingelheim Investigational Site
City
Antwerpen
Country
Belgium
Facility Name
9.159.1546 Boehringer Ingelheim Investigational Site
City
Bonheiden
Country
Belgium
Facility Name
9.159.1547 Boehringer Ingelheim Investigational Site
City
Brugge
Country
Belgium
Facility Name
9.159.1550 Boehringer Ingelheim Investigational Site
City
Bruxelles
Country
Belgium
Facility Name
9.159.1549 Boehringer Ingelheim Investigational Site
City
Hasselt
Country
Belgium
Facility Name
9.159.1555 Boehringer Ingelheim Investigational Site
City
Kortrijk
Country
Belgium
Facility Name
9.159.1554 Boehringer Ingelheim Investigational Site
City
La Louvière
Country
Belgium
Facility Name
9.159.1544 Boehringer Ingelheim Investigational Site
City
Leuven
Country
Belgium
Facility Name
9.159.1548 Boehringer Ingelheim Investigational Site
City
Montegnée
Country
Belgium
Facility Name
9.159.1556 Boehringer Ingelheim Investigational Site
City
Ottignies
Country
Belgium
Facility Name
9.159.1545 Boehringer Ingelheim Investigational Site
City
Wilrijk
Country
Belgium
Facility Name
9.159.1551 Boehringer Ingelheim Investigational Site
City
Yvoir
Country
Belgium
Facility Name
9.159.2869 Complexo Hospitalar Universitario Prof Edgard Santos
City
Salvador
Country
Brazil
Facility Name
9.159.2853 Boehringer Ingelheim Investigational Site
City
São Paulo
Country
Brazil
Facility Name
9.159.1397 Foothills Medical Centre
City
Calgary
State/Province
Alberta
Country
Canada
Facility Name
9.159.1382 Boehringer Ingelheim Investigational Site
City
Edmonton
State/Province
Alberta
Country
Canada
Facility Name
9.159.1390 Boehringer Ingelheim Investigational Site
City
Lethbridge
State/Province
Alberta
Country
Canada
Facility Name
9.159.1370 Boehringer Ingelheim Investigational Site
City
Kamloops
State/Province
British Columbia
Country
Canada
Facility Name
9.159.1368 Boehringer Ingelheim Investigational Site
City
New Westminster
State/Province
British Columbia
Country
Canada
Facility Name
9.159.1376 Boehringer Ingelheim Investigational Site
City
Penticton
State/Province
British Columbia
Country
Canada
Facility Name
9.159.1387 Boehringer Ingelheim Investigational Site
City
Vancouver
State/Province
British Columbia
Country
Canada
Facility Name
9.159.1377 Boehringer Ingelheim Investigational Site
City
Victoria
State/Province
British Columbia
Country
Canada
Facility Name
9.159.1355 Boehringer Ingelheim Investigational Site
City
Winnipeg
State/Province
Manitoba
Country
Canada
Facility Name
9.159.1394 Boehringer Ingelheim Investigational Site
City
Winnipeg
State/Province
Manitoba
Country
Canada
Facility Name
9.159.1356 Boehringer Ingelheim Investigational Site
City
Saint John
State/Province
New Brunswick
Country
Canada
Facility Name
9.159.1392 Boehringer Ingelheim Investigational Site
City
Corner Brook
State/Province
Newfoundland and Labrador
Country
Canada
Facility Name
9.159.1385 Boehringer Ingelheim Investigational Site
City
St. John's
State/Province
Newfoundland and Labrador
Country
Canada
Facility Name
9.159.1373 Boehringer Ingelheim Investigational Site
City
Sydney
State/Province
Nova Scotia
Country
Canada
Facility Name
9.159.1393 Boehringer Ingelheim Investigational Site
City
Barrie
State/Province
Ontario
Country
Canada
Facility Name
9.159.1395 Boehringer Ingelheim Investigational Site
City
Hamilton
State/Province
Ontario
Country
Canada
Facility Name
9.159.1360 Boehringer Ingelheim Investigational Site
City
Kingston
State/Province
Ontario
Country
Canada
Facility Name
9.159.1367 Boehringer Ingelheim Investigational Site
City
London
State/Province
Ontario
Country
Canada
Facility Name
9.159.1384 Boehringer Ingelheim Investigational Site
City
London
State/Province
Ontario
Country
Canada
Facility Name
9.159.1380 Boehringer Ingelheim Investigational Site
City
Mississauga
State/Province
Ontario
Country
Canada
Facility Name
9.159.1378 Boehringer Ingelheim Investigational Site
City
Ottawa
State/Province
Ontario
Country
Canada
Facility Name
9.159.1381 Ottawa Hospital General Campus
City
Ottawa
State/Province
Ontario
Country
Canada
Facility Name
9.159.1366 Boehringer Ingelheim Investigational Site
City
Richmond Hill
State/Province
Ontario
Country
Canada
Facility Name
9.159.1365 Boehringer Ingelheim Investigational Site
City
Scarborough
State/Province
Ontario
Country
Canada
Facility Name
9.159.1375 Boehringer Ingelheim Investigational Site
City
Scarborough
State/Province
Ontario
Country
Canada
Facility Name
9.159.1391 Boehringer Ingelheim Investigational Site
City
Tecumseh
State/Province
Ontario
Country
Canada
Facility Name
9.159.1369 Boehringer Ingelheim Investigational Site
City
Thunder Bay
State/Province
Ontario
Country
Canada
Facility Name
9.159.1357 Boehringer Ingelheim Investigational Site
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
9.159.1379 Boehringer Ingelheim Investigational Site
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
9.159.1383 Boehringer Ingelheim Investigational Site
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
9.159.1363 Boehringer Ingelheim Investigational Site
City
Windsor
State/Province
Ontario
Country
Canada
Facility Name
9.159.1359 Boehringer Ingelheim Investigational Site
City
Greenfield Park
State/Province
Quebec
Country
Canada
Facility Name
9.159.1361 Boehringer Ingelheim Investigational Site
City
Montreal
State/Province
Quebec
Country
Canada
Facility Name
9.159.1362 Boehringer Ingelheim Investigational Site
City
Montreal
State/Province
Quebec
Country
Canada
Facility Name
9.159.1371 Boehringer Ingelheim Investigational Site
City
Montreal
State/Province
Quebec
Country
Canada
Facility Name
9.159.1374 Boehringer Ingelheim Investigational Site
City
Montreal
State/Province
Quebec
Country
Canada
Facility Name
9.159.1388 Boehringer Ingelheim Investigational Site
City
Montreal
State/Province
Quebec
Country
Canada
Facility Name
9.159.1372 Boehringer Ingelheim Investigational Site
City
Quebec City
State/Province
Quebec
Country
Canada
Facility Name
9.159.1358 Boehringer Ingelheim Investigational Site
City
Saguenay
State/Province
Quebec
Country
Canada
Facility Name
9.159.1364 Boehringer Ingelheim Investigational Site
City
St. Jerome
State/Province
Quebec
Country
Canada
Facility Name
9.159.1389 Boehringer Ingelheim Investigational Site
City
Regina
State/Province
Saskatchewan
Country
Canada
Facility Name
9.159.1396 Boehringer Ingelheim Investigational Site
City
Saskatoon
State/Province
Saskatchewan
Country
Canada
Facility Name
9.159.2490 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2491 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2492 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2493 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2494 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2495 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2496 Boehringer Ingelheim Investigational Site
City
Beijing
Country
China
Facility Name
9.159.2503 Boehringer Ingelheim Investigational Site
City
Changchun, Jilin Province
Country
China
Facility Name
9.159.2500 Boehringer Ingelheim Investigational Site
City
Changsha, Hunan Province
Country
China
Facility Name
9.159.2513 Boehringer Ingelheim Investigational Site
City
Chengdu, Sichuan Province
Country
China
Facility Name
9.159.2512 Boehringer Ingelheim Investigational Site
City
Chongqing
Country
China
Facility Name
9.159.2507 Boehringer Ingelheim Investigational Site
City
Guangzhou, Guangdong Province
Country
China
Facility Name
9.159.2510 Boehringer Ingelheim Investigational Site
City
Guangzhou, Guangdong Province
Country
China
Facility Name
9.159.2509 Boehringer Ingelheim Investigational Site
City
Guangzhou
Country
China
Facility Name
9.159.2518 Boehringer Ingelheim Investigational Site
City
Guangzhou
Country
China
Facility Name
9.159.2521 Boehringer Ingelheim Investigational Site
City
Guangzhou
Country
China
Facility Name
9.159.2502 Boehringer Ingelheim Investigational Site
City
Hangzhou, Zhejiang Province
Country
China
Facility Name
9.159.2504 Boehringer Ingelheim Investigational Site
City
Harbin, Heilongjiang Province
Country
China
Facility Name
9.159.2505 Boehringer Ingelheim Investigational Site
City
Jinan, Shandong Province
Country
China
Facility Name
9.159.2506 Boehringer Ingelheim Investigational Site
City
Jinan, Shangdong Province
Country
China
Facility Name
9.159.2517 Boehringer Ingelheim Investigational Site
City
Nanjing, Jiangsu Province
Country
China
Facility Name
9.159.2519 Boehringer Ingelheim Investigational Site
City
Nanjing, Jiangsu Province
Country
China
Facility Name
9.159.2520 Boehringer Ingelheim Investigational Site
City
Nanjing, Jiangsu Province
Country
China
Facility Name
9.159.2483 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2484 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2485 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2486 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2487 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2488 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2489 Boehringer Ingelheim Investigational Site
City
Shanghai
Country
China
Facility Name
9.159.2516 Boehringer Ingelheim Investigational Site
City
Suzhou, Jiangsu Province
Country
China
Facility Name
9.159.2497 Boehringer Ingelheim Investigational Site
City
Tianjin
Country
China
Facility Name
9.159.2501 Boehringer Ingelheim Investigational Site
City
Wenzhou, Zhejiang Province
Country
China
Facility Name
9.159.2498 Boehringer Ingelheim Investigational Site
City
Wuhan, Hubei Province
Country
China
Facility Name
9.159.2499 Boehringer Ingelheim Investigational Site
City
Wuhan, Hubei Province
Country
China
Facility Name
9.159.2515 Boehringer Ingelheim Investigational Site
City
Xian, Shanxi Province
Country
China
Facility Name
9.159.2514 Boehringer Ingelheim Investigational Site
City
Xian, Shanxi
Country
China
Facility Name
9.159.2511 Boehringer Ingelheim Investigational Site
City
Xian
Country
China
Facility Name
9.159.1636 Boehringer Ingelheim Investigational Site
City
Aarhuc C
Country
Denmark
Facility Name
9.159.1635 Boehringer Ingelheim Investigational Site
City
Aarhus C
Country
Denmark
Facility Name
9.159.1639 Boehringer Ingelheim Investigational Site
City
Esbjerg
Country
Denmark
Facility Name
9.159.1634 Boehringer Ingelheim Investigational Site
City
Frederiksberg
Country
Denmark
Facility Name
9.159.1637 Boehringer Ingelheim Investigational Site
City
Glostrup
Country
Denmark
Facility Name
9.159.1640 Boehringer Ingelheim Investigational Site
City
Hellerup
Country
Denmark
Facility Name
9.159.1638 Boehringer Ingelheim Investigational Site
City
Hvidovre
Country
Denmark
Facility Name
9.159.1633 Boehringer Ingelheim Investigational Site
City
København NV
Country
Denmark
Facility Name
9.159.1631 Boehringer Ingelheim Investigational Site
City
København Ø
Country
Denmark
Facility Name
9.159.1632 Boehringer Ingelheim Investigational Site
City
Odense
Country
Denmark
Facility Name
9.159.2181 Boehringer Ingelheim Investigational Site
City
Oviedo
Country
El Salvador
Facility Name
9.159.1655 Boehringer Ingelheim Investigational Site
City
Helsinki
Country
Finland
Facility Name
9.159.1658 Boehringer Ingelheim Investigational Site
City
Kuopio
Country
Finland
Facility Name
9.159.1659 Boehringer Ingelheim Investigational Site
City
Lappeenranta
Country
Finland
Facility Name
9.159.1656 Boehringer Ingelheim Investigational Site
City
Oulu
Country
Finland
Facility Name
9.159.1657 Boehringer Ingelheim Investigational Site
City
Seinäjoki
Country
Finland
Facility Name
9.159.1680 Boehringer Ingelheim Investigational Site
City
Lille cedex
Country
France
Facility Name
9.159.1683 Boehringer Ingelheim Investigational Site
City
Limoges cedex 1
Country
France
Facility Name
9.159.1681 Boehringer Ingelheim Investigational Site
City
Marseille cedex 05
Country
France
Facility Name
9.159.1679 Boehringer Ingelheim Investigational Site
City
Nancy
Country
France
Facility Name
9.159.1685 Boehringer Ingelheim Investigational Site
City
Paris cedex 19
Country
France
Facility Name
9.159.1682 Boehringer Ingelheim Investigational Site
City
Poitiers cedex
Country
France
Facility Name
9.159.1684 Boehringer Ingelheim Investigational Site
City
Tours cedex 9
Country
France
Facility Name
9.159.1713 Boehringer Ingelheim Investigational Site
City
Bad Neustadt/Saale
Country
Germany
Facility Name
9.159.1736 Boehringer Ingelheim Investigational Site
City
Berlin
Country
Germany
Facility Name
9.159.1732 Boehringer Ingelheim Investigational Site
City
Braunschweig
Country
Germany
Facility Name
9.159.1726 Boehringer Ingelheim Investigational Site
City
Cloppenburg
Country
Germany
Facility Name
9.159.1723 Boehringer Ingelheim Investigational Site
City
Dresden
Country
Germany
Facility Name
9.159.1728 Boehringer Ingelheim Investigational Site
City
Düsseldorf
Country
Germany
Facility Name
9.159.1707 Boehringer Ingelheim Investigational Site
City
Essen
Country
Germany
Facility Name
9.159.1738 Boehringer Ingelheim Investigational Site
City
Freiburg
Country
Germany
Facility Name
9.159.1720 Boehringer Ingelheim Investigational Site
City
Gießen
Country
Germany
Facility Name
9.159.1722 Boehringer Ingelheim Investigational Site
City
Hamburg
Country
Germany
Facility Name
9.159.1739 Boehringer Ingelheim Investigational Site
City
Hamburg
Country
Germany
Facility Name
9.159.1724 Boehringer Ingelheim Investigational Site
City
Heidelberg
Country
Germany
Facility Name
9.159.1734 Boehringer Ingelheim Investigational Site
City
Jena
Country
Germany
Facility Name
9.159.1730 Boehringer Ingelheim Investigational Site
City
Kaiserslautern
Country
Germany
Facility Name
9.159.1737 Boehringer Ingelheim Investigational Site
City
Köln
Country
Germany
Facility Name
9.159.1717 Boehringer Ingelheim Investigational Site
City
Leipzig
Country
Germany
Facility Name
9.159.1735 Boehringer Ingelheim Investigational Site
City
Ludwigshafen am Rhein
Country
Germany
Facility Name
9.159.1712 Boehringer Ingelheim Investigational Site
City
Magdeburg
Country
Germany
Facility Name
9.159.1710 Boehringer Ingelheim Investigational Site
City
Mainz
Country
Germany
Facility Name
9.159.1709 Boehringer Ingelheim Investigational Site
City
Minden
Country
Germany
Facility Name
9.159.1716 Boehringer Ingelheim Investigational Site
City
Mönchengladbach
Country
Germany
Facility Name
9.159.1718 Boehringer Ingelheim Investigational Site
City
München
Country
Germany
Facility Name
9.159.1725 Boehringer Ingelheim Investigational Site
City
München
Country
Germany
Facility Name
9.159.1729 Boehringer Ingelheim Investigational Site
City
München
Country
Germany
Facility Name
9.159.1727 Boehringer Ingelheim Investigational Site
City
Münster
Country
Germany
Facility Name
9.159.1711 Boehringer Ingelheim Investigational Site
City
Nürnberg
Country
Germany
Facility Name
9.159.1719 Boehringer Ingelheim Investigational Site
City
Regensburg
Country
Germany
Facility Name
9.159.1731 Boehringer Ingelheim Investigational Site
City
Remscheid
Country
Germany
Facility Name
9.159.1708 Boehringer Ingelheim Investigational Site
City
Rostock
Country
Germany
Facility Name
9.159.1715 Boehringer Ingelheim Investigational Site
City
Saarbrücken
Country
Germany
Facility Name
9.159.1714 Boehringer Ingelheim Investigational Site
City
Siegen
Country
Germany
Facility Name
9.159.1733 Boehringer Ingelheim Investigational Site
City
Stuttgart
Country
Germany
Facility Name
9.159.1721 Boehringer Ingelheim Investigational Site
City
Weimar
Country
Germany
Facility Name
9.159.1826 Boehringer Ingelheim Investigational Site
City
Alexandroupolis
Country
Greece
Facility Name
9.159.1819 Boehringer Ingelheim Investigational Site
City
Athens
Country
Greece
Facility Name
9.159.1820 Boehringer Ingelheim Investigational Site
City
Athens
Country
Greece
Facility Name
9.159.1821 Boehringer Ingelheim Investigational Site
City
Athens
Country
Greece
Facility Name
9.159.1825 Boehringer Ingelheim Investigational Site
City
Ioannina
Country
Greece
Facility Name
9.159.1824 Boehringer Ingelheim Investigational Site
City
Patras
Country
Greece
Facility Name
9.159.2713 Boehringer Ingelheim Investigational Site
City
Hong KoNG
Country
Hong Kong
Facility Name
9.159.2714 Boehringer Ingelheim Investigational Site
City
Hong Kong
Country
Hong Kong
Facility Name
9.159.2605 Boehringer Ingelheim Investigational Site
City
Annamalainagar
Country
India
Facility Name
9.159.2603 Boehringer Ingelheim Investigational Site
City
Bangalore
Country
India
Facility Name
9.159.2620 Boehringer Ingelheim Investigational Site
City
Bangalore
Country
India
Facility Name
9.159.2616 Boehringer Ingelheim Investigational Site
City
Bikaner
Country
India
Facility Name
9.159.2618 Boehringer Ingelheim Investigational Site
City
Calicut
Country
India
Facility Name
9.159.2604 Boehringer Ingelheim Investigational Site
City
Chennai
Country
India
Facility Name
9.159.2619 Boehringer Ingelheim Investigational Site
City
Chennai
Country
India
Facility Name
9.159.2625 Boehringer Ingelheim Investigational Site
City
Chennai
Country
India
Facility Name
9.159.2606 Boehringer Ingelheim Investigational Site
City
Cochin
Country
India
Facility Name
9.159.2607 Boehringer Ingelheim Investigational Site
City
Hyderabad
Country
India
Facility Name
9.159.2624 Boehringer Ingelheim Investigational Site
City
Hyderabad
Country
India
Facility Name
9.159.2630 Boehringer Ingelheim Investigational Site
City
Hyderabad
Country
India
Facility Name
9.159.2632 Boehringer Ingelheim Investigational Site
City
Hyderabad
Country
India
Facility Name
9.159.2610 Boehringer Ingelheim Investigational Site
City
Indore
Country
India
Facility Name
9.159.2615 Boehringer Ingelheim Investigational Site
City
Jaipur
Country
India
Facility Name
9.159.2617 Boehringer Ingelheim Investigational Site
City
Jaipur
Country
India
Facility Name
9.159.2612 Boehringer Ingelheim Investigational Site
City
Jodhpur
Country
India
Facility Name
9.159.2621 Boehringer Ingelheim Investigational Site
City
Kottayam
Country
India
Facility Name
9.159.2613 Boehringer Ingelheim Investigational Site
City
Lucknow
Country
India
Facility Name
9.159.2614 Boehringer Ingelheim Investigational Site
City
Ludhiana
Country
India
Facility Name
9.159.2611 Boehringer Ingelheim Investigational Site
City
Mumbai
Country
India
Facility Name
9.159.2628 Boehringer Ingelheim Investigational Site
City
New Delhi
Country
India
Facility Name
9.159.2629 Boehringer Ingelheim Investigational Site
City
New Delhi
Country
India
Facility Name
9.159.2623 Boehringer Ingelheim Investigational Site
City
Patiala
Country
India
Facility Name
9.159.2609 Boehringer Ingelheim Investigational Site
City
Pune
Country
India
Facility Name
9.159.2622 Boehringer Ingelheim Investigational Site
City
Pune
Country
India
Facility Name
9.159.2627 Boehringer Ingelheim Investigational Site
City
Secunderabad
Country
India
Facility Name
9.159.2626 Boehringer Ingelheim Investigational Site
City
Trichy
Country
India
Facility Name
9.159.2631 Boehringer Ingelheim Investigational Site
City
Visakhapatnam
Country
India
Facility Name
9.159.2608 Boehringer Ingelheim Investigational Site
City
Wardha
Country
India
Facility Name
9.159.1851 Boehringer Ingelheim Investigational Site
City
Cork
Country
Ireland
Facility Name
9.159.1852 Boehringer Ingelheim Investigational Site
City
Dublin 7
Country
Ireland
Facility Name
9.159.2729 Barzilai Medical Center
City
Ashkelon
Country
Israel
Facility Name
9.159.2721 Neurology Unit
City
Haifa
Country
Israel
Facility Name
9.159.2724 Rambam Medical Center, Tel-Aviv Medical
City
Haifa
Country
Israel
Facility Name
9.159.2723 Boehringer Ingelheim Investigational Site
City
Israel
Country
Israel
Facility Name
9.159.2727 Western Galilee Hospital
City
Naharia
Country
Israel
Facility Name
9.159.2722 Neurology Unit
City
Petach Tikva
Country
Israel
Facility Name
9.159.2726 Sheba Medical Center
City
Tel Hashomer
Country
Israel
Facility Name
9.159.2725 Tel Aviv Medical Center
City
Tel-Aviv
Country
Israel
Facility Name
9.159.1875 Università degli Studi di Ancona
City
Ancona
Country
Italy
Facility Name
9.159.1882 Ospedale Brotzu
City
Cagliari
Country
Italy
Facility Name
9.159.1883 Azienda Ospedaliera S. Anna
City
Como
Country
Italy
Facility Name
9.159.1871 Azienda Ospedaliera "Careggi"
City
Firenze
Country
Italy
Facility Name
9.159.1869 Università degli Studi di Genova
City
Genova
Country
Italy
Facility Name
9.159.1870 ASL No. 5 di Jesi
City
Jesi (ancona)
Country
Italy
Facility Name
9.159.1865 Ospedale Regionale "S. Salvatore"
City
L'aquila
Country
Italy
Facility Name
9.159.1866 Ospedale S. Raffaele
City
Milano
Country
Italy
Facility Name
9.159.1873 Istituto Scientifico "S. Luca"
City
Milano
Country
Italy
Facility Name
9.159.1884 Ospedale S. Carlo Borromeo"
City
Milano
Country
Italy
Facility Name
9.159.1868 Ospedale "S. Maria di Loreto Mare"
City
Napoli
Country
Italy
Facility Name
9.159.1876 Azienda Ospedaliera di Padova -Policlinico Universitario
City
Padova
Country
Italy
Facility Name
9.159.1874 Ospedale Civico - ARNAS
City
Palermo
Country
Italy
Facility Name
9.159.1872 Neuromed IRCCS
City
Pozzilli (IS)
Country
Italy
Facility Name
9.159.1879 Policlinico S. Andrea
City
Roma
Country
Italy
Facility Name
9.159.1881 Università "La Sapienza"
City
Roma
Country
Italy
Facility Name
9.159.1877 Azienda Ospedaliera Umberto I
City
Siracusa
Country
Italy
Facility Name
9.159.1878 Azienda Ospedaliera "Santo Maria"
City
Terni
Country
Italy
Facility Name
9.159.1864 Azienda Ospedaliera "S. Giovanni Battista"
City
Torino
Country
Italy
Facility Name
9.159.1863 Ospedale di Cattinara
City
Trieste
Country
Italy
Facility Name
9.159.1867 Presidio Ospedaliero G.Jazzolino
City
Vibo Valentia
Country
Italy
Facility Name
9.159.1880 Ospedale Civile
City
Vicenza
Country
Italy
Facility Name
9.159.2964 Boehringer Ingelheim Investigational Site
City
Adachi-ku, Tokyo
Country
Japan
Facility Name
9.159.2958 Boehringer Ingelheim Investigational Site
City
Akashi, Hyogo
Country
Japan
Facility Name
9.159.2970 Boehringer Ingelheim Investigational Site
City
Akashi, Hyogo
Country
Japan
Facility Name
9.159.2965 Boehringer Ingelheim Investigational Site
City
Ako, Hyogo
Country
Japan
Facility Name
9.159.2968 Boehringer Ingelheim Investigational Site
City
Aoba-ku, Yokohama, Kanagawa
Country
Japan
Facility Name
9.159.2951 Boehringer Ingelheim Investigational Site
City
Azumino, Nagano
Country
Japan
Facility Name
9.159.2959 Boehringer Ingelheim Investigational Site
City
Chitose, Hokkaido
Country
Japan
Facility Name
9.159.2944 Boehringer Ingelheim Investigational Site
City
Chuo-ku, Kobe, Hyogo
Country
Japan
Facility Name
9.159.2947 Boehringer Ingelheim Investigational Site
City
Chuo-Ku, Sapporo, Hokkaido
Country
Japan
Facility Name
9.159.2954 Boehringer Ingelheim Investigational Site
City
Fushimi-ku, Kyoto, Kyoto
Country
Japan
Facility Name
9.159.2942 Boehringer Ingelheim Investigational Site
City
Habikino, Osaka
Country
Japan
Facility Name
9.159.2948 Boehringer Ingelheim Investigational Site
City
Higashi-ku, Sapporo, Hokkaido
Country
Japan
Facility Name
9.159.2957 Boehringer Ingelheim Investigational Site
City
Higashi-osaka, Osaka
Country
Japan
Facility Name
9.159.2940 Boehringer Ingelheim Investigational Site
City
Higashinari-ku, Osaka, Osaka
Country
Japan
Facility Name
9.159.2973 Boehringer Ingelheim Investigational Site
City
Higashiyodogawa-ku, Osaka, Osaka
Country
Japan
Facility Name
9.159.2949 Boehringer Ingelheim Investigational Site
City
Hitachinaka, Ibaraki
Country
Japan
Facility Name
9.159.2953 Boehringer Ingelheim Investigational Site
City
Iida, Nagano
Country
Japan
Facility Name
9.159.2943 Boehringer Ingelheim Investigational Site
City
Izumisano, Osaka
Country
Japan
Facility Name
9.159.2963 Boehringer Ingelheim Investigational Site
City
Jyonan-ku, Fukuoka, Fukuoka
Country
Japan
Facility Name
9.159.2933 Boehringer Ingelheim Investigational Site
City
Kasama, Ibaraki
Country
Japan
Facility Name
9.159.2955 Boehringer Ingelheim Investigational Site
City
Kasuga, Fukuoka
Country
Japan
Facility Name
9.159.2938 Boehringer Ingelheim Investigational Site
City
Kita-ku, Osaka, Osaka
Country
Japan
Facility Name
9.159.2967 Boehringer Ingelheim Investigational Site
City
Koriyama, Fukushima
Country
Japan
Facility Name
9.159.2969 Boehringer Ingelheim Investigational Site
City
Kushiro, Hokkaido
Country
Japan
Facility Name
9.159.2952 Boehringer Ingelheim Investigational Site
City
Matsumoto, Nagano
Country
Japan
Facility Name
9.159.2961 Boehringer Ingelheim Investigational Site
City
Midori-ku, Yokohama, Kanagawa
Country
Japan
Facility Name
9.159.2934 Boehringer Ingelheim Investigational Site
City
Moriya, Ibaraki
Country
Japan
Facility Name
9.159.2971 Boehringer Ingelheim Investigational Site
City
Musashino, Tokyo
Country
Japan
Facility Name
9.159.2962 Boehringer Ingelheim Investigational Site
City
Nakagawa-ku, Nagoya, Aichi
Country
Japan
Facility Name
9.159.2939 Boehringer Ingelheim Investigational Site
City
Nishi-yodogawa-ku, Osaka, Osaka
Country
Japan
Facility Name
9.159.2956 Boehringer Ingelheim Investigational Site
City
Ohnojo, Fukuoka
Country
Japan
Facility Name
9.159.2941 Boehringer Ingelheim Investigational Site
City
Sakai-ku, Sakai, Osaka
Country
Japan
Facility Name
9.159.2945 Boehringer Ingelheim Investigational Site
City
Sawara-ku, Fukuoka, Fukuoka
Country
Japan
Facility Name
9.159.2937 Boehringer Ingelheim Investigational Site
City
Shimogyo-ku, Kyoto, Kyoto
Country
Japan
Facility Name
9.159.2966 Boehringer Ingelheim Investigational Site
City
Shiroishi, Miyagi
Country
Japan
Facility Name
9.159.2936 Boehringer Ingelheim Investigational Site
City
Suwa, Nagano
Country
Japan
Facility Name
9.159.2946 Boehringer Ingelheim Investigational Site
City
Takikawa, Hokkaido
Country
Japan
Facility Name
9.159.2935 Boehringer Ingelheim Investigational Site
City
Tatebayashi, Gunma
Country
Japan
Facility Name
9.159.2950 Boehringer Ingelheim Investigational Site
City
Tsuchiura, Ibaraki
Country
Japan
Facility Name
9.159.2972 Boehringer Ingelheim Investigational Site
City
Yao, Osaka
Country
Japan
Facility Name
9.159.1593 Boehringer Ingelheim Investigational Site
City
Gwangju
Country
Korea, Republic of
Facility Name
9.159.1595 Boehringer Ingelheim Investigational Site
City
Incheon
Country
Korea, Republic of
Facility Name
9.159.1592 Boehringer Ingelheim Investigational Site
City
Kyunggi-do
Country
Korea, Republic of
Facility Name
9.159.1591 Boehringer Ingelheim Investigational Site
City
Seoul
Country
Korea, Republic of
Facility Name
9.159.1594 Boehringer Ingelheim Investigational Site
City
Seoul
Country
Korea, Republic of
Facility Name
9.159.1597 Boehringer Ingelheim Investigational Site
City
Seoul
Country
Korea, Republic of
Facility Name
9.159.1596 Boehringer Ingelheim Investigational Site
City
Suwon
Country
Korea, Republic of
Facility Name
9.159.2707 Boehringer Ingelheim Investigational Site
City
Kelantan Darul Naim
Country
Malaysia
Facility Name
9.159.2706 Boehringer Ingelheim Investigational Site
City
Kuala Lumpur
Country
Malaysia
Facility Name
9.159.2765 Boehringer Ingelheim Investigational Site
City
Metepec
Country
Mexico
Facility Name
9.159.1960 Jeroen Bosch Ziekenhuis
City
's-Hertogenbosch
Country
Netherlands
Facility Name
9.159.1945 Medisch Centrum Alkmaar
City
Alkmaar
Country
Netherlands
Facility Name
9.159.1963 Polikliniek Neurologie
City
Assen
Country
Netherlands
Facility Name
9.159.1949 Ziekenhuis Gooi-Noord
City
Blaricum
Country
Netherlands
Facility Name
9.159.1962 Locatie Molengracht
City
Breda
Country
Netherlands
Facility Name
9.159.1950 HagaZiekenhuis
City
Den Haag
Country
Netherlands
Facility Name
9.159.1959 Catharina Ziekenhuis
City
Eindhoven
Country
Netherlands
Facility Name
9.159.1946 Scheper Ziekenhuis
City
Emmen
Country
Netherlands
Facility Name
9.159.1958 Medisch Spectrum Twente
City
Enschede
Country
Netherlands
Facility Name
9.159.1943 Umcg
City
Groningen
Country
Netherlands
Facility Name
9.159.1961 Lokatie Van Swieten
City
Groningen
Country
Netherlands
Facility Name
9.159.1953 Atrium Medisch Centrum
City
Heerlen
Country
Netherlands
Facility Name
9.159.1955 Elkerliek Ziekenhuis
City
Helmond
Country
Netherlands
Facility Name
9.159.1951 Ziekenhuisgroep Twente
City
Hengelo
Country
Netherlands
Facility Name
9.159.1948 Medisch Centrum Leeuwarden
City
Leeuwarden
Country
Netherlands
Facility Name
9.159.1952 Rijnland Ziekenhuis
City
Leiderdorp
Country
Netherlands
Facility Name
9.159.1947 Sint Antonius Ziekenhuis
City
Nieuwegein
Country
Netherlands
Facility Name
9.159.1964 Canisius-Wilhelmina ziekenhuis
City
Nijmegen
Country
Netherlands
Facility Name
9.159.1956 TweeSteden Ziekenhuis Tilburg
City
Tilburg
Country
Netherlands
Facility Name
9.159.1957 Sint Elisabeth Ziekenhuis
City
Tilburg
Country
Netherlands
Facility Name
9.159.1944 Máxima Medisch Centrum
City
Veldhoven
Country
Netherlands
Facility Name
9.159.1954 St. Jans Gasthuis
City
Weert
Country
Netherlands
Facility Name
9.159.2029 Boehringer Ingelheim Investigational Site
City
Bergen
Country
Norway
Facility Name
9.159.2028 Boehringer Ingelheim Investigational Site
City
Oslo
Country
Norway
Facility Name
9.159.2027 Boehringer Ingelheim Investigational Site
City
Trondheim
Country
Norway
Facility Name
9.159.2040 Hospital Fernando Fonseca
City
Amadora
Country
Portugal
Facility Name
9.159.2039 Centro Hospitalar e Universitário de Coimbra, EPE
City
Coimbra
Country
Portugal
Facility Name
9.159.2041 Centro Hospitalar de Lisboa Norte
City
Lisboa
Country
Portugal
Facility Name
9.159.2042 Centro Hospitalar do Porto
City
Porto
Country
Portugal
Facility Name
9.159.2114 Boehringer Ingelheim Investigational Site
City
Ekaterinburg
Country
Russian Federation
Facility Name
9.159.2102 Boehringer Ingelheim Investigational Site
City
Kazan
Country
Russian Federation
Facility Name
9.159.2117 Boehringer Ingelheim Investigational Site
City
Kemerovo
Country
Russian Federation
Facility Name
9.159.2107 Boehringer Ingelheim Investigational Site
City
Kirov
Country
Russian Federation
Facility Name
9.159.2116 Boehringer Ingelheim Investigational Site
City
Krasnoyarsk
Country
Russian Federation
Facility Name
9.159.2079 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2080 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2081 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2082 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2083 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2084 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2085 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2087 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2088 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2089 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2090 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2091 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2092 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2093 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2095 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2098 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2101 Boehringer Ingelheim Investigational Site
City
Moscow
Country
Russian Federation
Facility Name
9.159.2105 Boehringer Ingelheim Investigational Site
City
Nizhnyi Novgorod
Country
Russian Federation
Facility Name
9.159.2115 Boehringer Ingelheim Investigational Site
City
Novosibirsk
Country
Russian Federation
Facility Name
9.159.2119 Boehringer Ingelheim Investigational Site
City
Omsk
Country
Russian Federation
Facility Name
9.159.2111 Boehringer Ingelheim Investigational Site
City
Orel
Country
Russian Federation
Facility Name
9.159.2106 Boehringer Ingelheim Investigational Site
City
Rostov-na-Donu
Country
Russian Federation
Facility Name
9.159.2108 Boehringer Ingelheim Investigational Site
City
Samara
Country
Russian Federation
Facility Name
9.159.2109 Boehringer Ingelheim Investigational Site
City
Saratov
Country
Russian Federation
Facility Name
9.159.2110 Boehringer Ingelheim Investigational Site
City
Saratov
Country
Russian Federation
Facility Name
9.159.2118 Boehringer Ingelheim Investigational Site
City
Seversk
Country
Russian Federation
Facility Name
9.159.2086 Boehringer Ingelheim Investigational Site
City
Smolensk
Country
Russian Federation
Facility Name
9.159.2094 Boehringer Ingelheim Investigational Site
City
St. Petersburg
Country
Russian Federation
Facility Name
9.159.2097 Boehringer Ingelheim Investigational Site
City
St. Petersburg
Country
Russian Federation
Facility Name
9.159.2099 Boehringer Ingelheim Investigational Site
City
St. Petersburg
Country
Russian Federation
Facility Name
9.159.2100 Boehringer Ingelheim Investigational Site
City
St. Petersburg
Country
Russian Federation
Facility Name
9.159.2120 Boehringer Ingelheim Investigational Site
City
Ufa
Country
Russian Federation
Facility Name
9.159.2112 Boehringer Ingelheim Investigational Site
City
Volgograd
Country
Russian Federation
Facility Name
9.159.2113 Boehringer Ingelheim Investigational Site
City
Volgograd
Country
Russian Federation
Facility Name
9.159.2104 Boehringer Ingelheim Investigational Site
City
Voronezh
Country
Russian Federation
Facility Name
9.159.2103 Boehringer Ingelheim Investigational Site
City
Yaroslavl
Country
Russian Federation
Facility Name
9.159.2703 Boehringer Ingelheim Investigational Site
City
Singapore
Country
Singapore
Facility Name
9.159.2704 Boehringer Ingelheim Investigational Site
City
Singapore
Country
Singapore
Facility Name
9.159.2705 Boehringer Ingelheim Investigational Site
City
Singapore
Country
Singapore
Facility Name
9.159.2060 Boehringer Ingelheim Investigational Site
City
Bloemfontein
Country
South Africa
Facility Name
9.159.2056 Boehringer Ingelheim Investigational Site
City
Cape Town
Country
South Africa
Facility Name
9.159.2057 Boehringer Ingelheim Investigational Site
City
Durban
Country
South Africa
Facility Name
9.159.2055 Boehringer Ingelheim Investigational Site
City
Johannesburg
Country
South Africa
Facility Name
9.159.2061 Boehringer Ingelheim Investigational Site
City
Johannesburg
Country
South Africa
Facility Name
9.159.2058 Boehringer Ingelheim Investigational Site
City
Pretoria
Country
South Africa
Facility Name
9.159.2059 Boehringer Ingelheim Investigational Site
City
Sunninghill
Country
South Africa
Facility Name
9.159.2179 Boehringer Ingelheim Investigational Site
City
Alicante
Country
Spain
Facility Name
9.159.2177 Boehringer Ingelheim Investigational Site
City
Barcelona
Country
Spain
Facility Name
9.159.2178 Boehringer Ingelheim Investigational Site
City
Hospitalet de Llobregat (Barcelona)
Country
Spain
Facility Name
9.159.2175 Boehringer Ingelheim Investigational Site
City
Madrid
Country
Spain
Facility Name
9.159.2176 Boehringer Ingelheim Investigational Site
City
Madrid
Country
Spain
Facility Name
9.159.2180 Boehringer Ingelheim Investigational Site
City
Pamplona
Country
Spain
Facility Name
9.159.2223 Boehringer Ingelheim Investigational Site
City
Borås
Country
Sweden
Facility Name
9.159.2209 Boehringer Ingelheim Investigational Site
City
Eskilstuna
Country
Sweden
Facility Name
9.159.2204 Boehringer Ingelheim Investigational Site
City
Göteborg
Country
Sweden
Facility Name
9.159.2205 Boehringer Ingelheim Investigational Site
City
Göteborg
Country
Sweden
Facility Name
9.159.2728 Neurology Unit
City
Holon
Country
Sweden
Facility Name
9.159.2210 Boehringer Ingelheim Investigational Site
City
Jönköping
Country
Sweden
Facility Name
9.159.2206 Boehringer Ingelheim Investigational Site
City
Lund
Country
Sweden
Facility Name
9.159.2211 Boehringer Ingelheim Investigational Site
City
Mora
Country
Sweden
Facility Name
9.159.2216 Boehringer Ingelheim Investigational Site
City
Skellefteå
Country
Sweden
Facility Name
9.159.2215 Boehringer Ingelheim Investigational Site
City
Skövde
Country
Sweden
Facility Name
9.159.2203 Boehringer Ingelheim Investigational Site
City
Stockholm
Country
Sweden
Facility Name
9.159.2212 Boehringer Ingelheim Investigational Site
City
Stockholm
Country
Sweden
Facility Name
9.159.2213 Boehringer Ingelheim Investigational Site
City
Stockholm
Country
Sweden
Facility Name
9.159.2222 Boehringer Ingelheim Investigational Site
City
Stockholm
Country
Sweden
Facility Name
9.159.2225 Boehringer Ingelheim Investigational Site
City
Stockholm
Country
Sweden
Facility Name
9.159.2207 Boehringer Ingelheim Investigational Site
City
Umeå
Country
Sweden
Facility Name
9.159.2214 Boehringer Ingelheim Investigational Site
City
Värnamo
Country
Sweden
Facility Name
9.159.2224 Boehringer Ingelheim Investigational Site
City
Västervik
Country
Sweden
Facility Name
9.159.2208 Boehringer Ingelheim Investigational Site
City
Örebro
Country
Sweden
Facility Name
9.159.2250 Boehringer Ingelheim Investigational Site
City
Kaohsiung
Country
Taiwan
Facility Name
9.159.2253 Boehringer Ingelheim Investigational Site
City
Kaohsiung
Country
Taiwan
Facility Name
9.159.2248 Boehringer Ingelheim Investigational Site
City
Taichung
Country
Taiwan
Facility Name
9.159.2249 Boehringer Ingelheim Investigational Site
City
Taichung
Country
Taiwan
Facility Name
9.159.2251 Boehringer Ingelheim Investigational Site
City
Tainan
Country
Taiwan
Facility Name
9.159.2244 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2245 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2246 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2247 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2252 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2254 Boehringer Ingelheim Investigational Site
City
Taipei
Country
Taiwan
Facility Name
9.159.2243 Boehringer Ingelheim Investigational Site
City
Taoyuan
Country
Taiwan
Facility Name
9.159.2797 Boehringer Ingelheim Investigational Site
City
Bangkok
Country
Thailand
Facility Name
9.159.2798 Boehringer Ingelheim Investigational Site
City
Bangkok
Country
Thailand
Facility Name
9.159.2799 Boehringer Ingelheim Investigational Site
City
Bangkok
Country
Thailand
Facility Name
9.159.2800 Boehringer Ingelheim Investigational Site
City
Bangkok
Country
Thailand
Facility Name
9.159.2801 Boehringer Ingelheim Investigational Site
City
Chiang Mai
Country
Thailand
Facility Name
9.159.2830 Boehringer Ingelheim Investigational Site
City
Ankara
Country
Turkey
Facility Name
9.159.2829 Boehringer Ingelheim Investigational Site
City
Antalya
Country
Turkey
Facility Name
9.159.2831 Boehringer Ingelheim Investigational Site
City
Bursa
Country
Turkey
Facility Name
9.159.2827 Boehringer Ingelheim Investigational Site
City
Eskisehir
Country
Turkey
Facility Name
9.159.2825 Boehringer Ingelheim Investigational Site
City
Istanbul
Country
Turkey
Facility Name
9.159.2826 Boehringer Ingelheim Investigational Site
City
Istanbul
Country
Turkey
Facility Name
9.159.2828 Dkuz Eylul Universitesi Tip Fakultesi Noroloji A.B.D.
City
Izmir
Country
Turkey
Facility Name
9.159.2387 Boehringer Ingelheim Investigational Site
City
Dnepropetrovsk
Country
Ukraine
Facility Name
9.159.2384 Boehringer Ingelheim Investigational Site
City
Kharkiv
Country
Ukraine
Facility Name
9.159.2385 Boehringer Ingelheim Investigational Site
City
Kharkiv
Country
Ukraine
Facility Name
9.159.2386 Boehringer Ingelheim Investigational Site
City
Kharkiv
Country
Ukraine
Facility Name
9.159.2392 Boehringer Ingelheim Investigational Site
City
Kharkiv
Country
Ukraine
Facility Name
9.159.2379 Boehringer Ingelheim Investigational Site
City
Kyiv
Country
Ukraine
Facility Name
9.159.2380 Boehringer Ingelheim Investigational Site
City
Kyiv
Country
Ukraine
Facility Name
9.159.2382 Boehringer Ingelheim Investigational Site
City
Kyiv
Country
Ukraine
Facility Name
9.159.2389 Boehringer Ingelheim Investigational Site
City
Odesa
Country
Ukraine
Facility Name
9.159.2390 Boehringer Ingelheim Investigational Site
City
Odesa
Country
Ukraine
Facility Name
9.159.2391 Boehringer Ingelheim Investigational Site
City
Vinnytzya
Country
Ukraine
Facility Name
9.159.2388 Boehringer Ingelheim Investigational Site
City
Zaporizhzhya
Country
Ukraine
Facility Name
9.159.2304 Boehringer Ingelheim Investigational Site
City
Belfast
Country
United Kingdom
Facility Name
9.159.2297 Boehringer Ingelheim Investigational Site
City
Birmingham
Country
United Kingdom
Facility Name
9.159.2299 Boehringer Ingelheim Investigational Site
City
Bournemouth
Country
United Kingdom
Facility Name
9.159.2301 Boehringer Ingelheim Investigational Site
City
Bristol
Country
United Kingdom
Facility Name
9.159.2298 Boehringer Ingelheim Investigational Site
City
Dundee
Country
United Kingdom
Facility Name
9.159.2307 Boehringer Ingelheim Investigational Site
City
Exeter
Country
United Kingdom
Facility Name
9.159.2296 Boehringer Ingelheim Investigational Site
City
Glasgow
Country
United Kingdom
Facility Name
9.159.2300 Boehringer Ingelheim Investigational Site
City
Glasgow
Country
United Kingdom
Facility Name
9.159.2287 Boehringer Ingelheim Investigational Site
City
Harrow
Country
United Kingdom
Facility Name
9.159.2303 Boehringer Ingelheim Investigational Site
City
Henshingham, Whitehaven
Country
United Kingdom
Facility Name
9.159.2308 Boehringer Ingelheim Investigational Site
City
Leicester
Country
United Kingdom
Facility Name
9.159.2295 Boehringer Ingelheim Investigational Site
City
Liverpool
Country
United Kingdom
Facility Name
9.159.2286 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
9.159.2293 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
9.159.2294 Boehringer Ingelheim Investigational Site
City
London
Country
United Kingdom
Facility Name
9.159.2305 Boehringer Ingelheim Investigational Site
City
Mansfield
Country
United Kingdom
Facility Name
9.159.2290 Boehringer Ingelheim Investigational Site
City
Newcastle Upon Tyne
Country
United Kingdom
Facility Name
9.159.2288 Boehringer Ingelheim Investigational Site
City
North Shields
Country
United Kingdom
Facility Name
9.159.2285 Boehringer Ingelheim Investigational Site
City
Northampton
Country
United Kingdom
Facility Name
9.159.2284 Boehringer Ingelheim Investigational Site
City
Nottingham
Country
United Kingdom
Facility Name
9.159.2283 Boehringer Ingelheim Investigational Site
City
Poole
Country
United Kingdom
Facility Name
9.159.2302 Boehringer Ingelheim Investigational Site
City
Rotherham
Country
United Kingdom
Facility Name
9.159.2292 Boehringer Ingelheim Investigational Site
City
Sheffield
Country
United Kingdom
Facility Name
9.159.2289 Boehringer Ingelheim Investigational Site
City
Southampton
Country
United Kingdom
Facility Name
9.159.2306 Boehringer Ingelheim Investigational Site
City
Stoke on Trent
Country
United Kingdom
Facility Name
9.159.2291 Boehringer Ingelheim Investigational Site
City
Sunderland
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
23988639
Citation
Ovbiagele B, Bath PM, Cotton D, Sha N, Diener HC; PRoFESS Investigators. Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation. Stroke. 2013 Nov;44(11):3223-5. doi: 10.1161/STROKEAHA.113.002463. Epub 2013 Aug 29.
Results Reference
derived
PubMed Identifier
22922507
Citation
Bohm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. 2012 Nov;33(22):2804-12. doi: 10.1093/eurheartj/ehs250. Epub 2012 Aug 26.
Results Reference
derived
PubMed Identifier
22738922
Citation
Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Moller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke. 2012 Sep;43(9):2336-42. doi: 10.1161/STROKEAHA.111.648576. Epub 2012 Jun 26.
Results Reference
derived
PubMed Identifier
22267825
Citation
Weber R, Weimar C, Wanke I, Moller-Hartmann C, Gizewski ER, Blatchford J, Hermansson K, Demchuk AM, Forsting M, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group. Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy. Stroke. 2012 Feb;43(2):350-5. doi: 10.1161/STROKEAHA.111.631739. Epub 2012 Jan 19.
Results Reference
derived
PubMed Identifier
22089721
Citation
Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM; PROFESS Investigators. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011 Nov 16;306(19):2137-44. doi: 10.1001/jama.2011.1650.
Results Reference
derived
PubMed Identifier
18757238
Citation
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Erratum In: Lancet Neurol. 2008 Nov;7(11):985.
Results Reference
derived
PubMed Identifier
18753639
Citation
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.
Results Reference
derived
PubMed Identifier
18753638
Citation
Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.
Results Reference
derived
Links:
URL
http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/9/9.159_U08-3667.pdf
Description
Related Info
URL
http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/9/9.159_literature.pdf
Description
Related Info

Learn more about this trial

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

We'll reach out to this number within 24 hrs